Annual Report 2024
Disclaimer
The European Chemicals Agency is not responsible for the use that may be made of the
information contained in this document.
Europe Direct is a service to help you find answers to your questions about the European
Union.
Freephone number (*):
00 800 6 7 8 9 10 11
(*) Certain mobile telephone operators do not allow access to 00 800 numbers or these calls may be billed.
More information on the European Union is available on the Internet (http://europa.eu).
Annual Report 2024
Reference: ECHA-25-R-03-EN
ISBN: 978-92-9468-469-1
ISSN: 2600-0849
Cat. Number: ED-01-25-003-EN-N
DOI: 10.2823/7460332
Publ.date: April 2025
Language: EN
© European Chemicals Agency, 2025
Cover page © European Chemicals Agency
If you have questions or comments in relation to this document, please send them (quote the
reference and issue date) using the information request form. The information request form can
be accessed via the Contact ECHA page at: http://echa.europa.eu/contact
European Chemicals Agency
P.O. Box 400, FI-00121 Helsinki, Finland
3
Annual Report 2024
Table of Contents
TABLE OF CONTENTS .................................................................................................. 3
LIST OF ACRONYMS .................................................................................................... 5
MANAGEMENT BOARD ANALYSIS AND ASSESSMENT .................................................. 8
FOREWORD............................................................................................................... 13
EXECUTIVE SUMMARY .............................................................................................. 15
PART I. ACHIEVEMENTS OF THE YEAR ...................................................................... 20
Dossier preparation ................................................................................................................. 20
Dossier submission and processing ............................................................................................ 21
Identification and prioritisation of substances and groups of substances .......................................... 23
Evaluation ............................................................................................................................. 24
Authorisation.......................................................................................................................... 26
Restrictions ............................................................................................................................ 28
Classification and labelling........................................................................................................ 30
Data management and dissemination ........................................................................................ 33
Promotion of alternatives to animal testing ................................................................................. 35
Biocides ................................................................................................................................. 37
Contribution to EU Environmental policy ..................................................................................... 39
Tasks under grant, cooperation and service-level agreements ....................................................... 44
Governance and Enablers ......................................................................................................... 47
PART II. MANAGEMENT ............................................................................................ 61
Management Board ................................................................................................................. 61
Major developments ................................................................................................................ 61
Budgetary and financial management ........................................................................................ 62
Delegation and sub-delegation of the powers of budget implementation to agency’s Staff .................. 62
Human Resources (HR) management ......................................................................................... 62
Strategy for efficiency gains ..................................................................................................... 62
Assessment of audit and retrospective evaluation results during the reporting year .......................... 63
Follow up of recommendations and action plans for audits and evaluations ...................................... 66
Follow up of observations from the Discharge authority ................................................................ 66
Environment management ....................................................................................................... 67
Assessment by management .................................................................................................... 69
PART III. ASSESSMENT OF THE EFFECTIVENESS OF THE INTERNAL CONTROL SYSTEMS
........................................................................................................................... 70
Effectiveness of internal control system ...................................................................................... 70
Conclusions of the assessment of the internal control systems ....................................................... 75
Statement of the manager in charge of risk management and internal control ................................. 77
PART IV. MANAGEMENT ASSURANCE ........................................................................ 78
Review of the elements supporting assurance ............................................................................. 78
Reservations .......................................................................................................................... 78
PART V. DECLARATION OF ASSURANCE .................................................................... 79
Declaration of assurance by the Authorising Officer ...................................................................... 79
ANNEXES .................................................................................................................. 80
Annex I - Key indicators ........................................................................................................... 81
Annex II - Budget implementation reports and statistics on financial management ........................... 82
Revenue .............................................................................................................................. 82
REACH/CLP Revenue .............................................................................................................. 83
BPR Revenue ........................................................................................................................ 83
Environmental Policy Revenue ................................................................................................. 84
Expenditure .......................................................................................................................... 86
Annex III – Organisational chart ............................................................................................... 94
4
Annual Report 2024
Annex IV - Establishment plan and additional information on human resources management ............. 95
Annex V – Human and financial resources by activity ..................................................................100
Annex VI – Contribution, grant and service-level agreements .......................................................101
Annex VII - Environment management......................................................................................102
5
Annual Report 2024
List of acronyms
Acronym Description Acronym Description
AD Administrator and Innovation
AI Artificial Intelligence DNA Designated national authorities
APCRA Accelerating the Pace of Chemical DoI Declaration of Interests
Risk Assessment
DWD Drinking Water Directive
ARN Assessment of regulatory needs
EAP Environmental Action Programme
ASO Accredited Stakeholder
EC European Commission
Organisation
ECA European Court of Auditors
AST Assistant
ECDC European Centre for Disease
BAT Best Available Technique
Control
BEF BPR-EN-FORCE (Forum-
ECHA European Chemicals Agency
coordinated BPR enforcement
project) eChemPortal OECD Global Portal to
Information on Chemical
BoA Board of Appeal
Substances
BPC Biocidal Products Committee
ED Endocrine disruptor
BPR Biocidal Products Regulation
EDPS European Data Protection
BPRS BPR Subgroup of the Forum Supervisor
BREF Best Available Techniques EEA European Environment Agency
Reference documents
EFSA European Food Safety Authority
C&L Classification and labelling
EFTA European Free Trade Association
CA Contract agent
ELV End-of-Life Vehicle
Chesar Chemical Safety Assessment and
EMA European Medicines Agency
Reporting tool
EMAS EU Eco-Management and Audit
CLH Harmonised classification and
Scheme
labelling
EMS Environmental management
CLP Classification, labelling and
system
packaging (and the respective
Regulation) eMSCA Evaluating Member State
competent authority
CoIAC Conflict of Interest Advisory
Committee ENVI European Parliament's Committee
on Environment, Public Health
COM European Commission
and Food Safety
CoRAP Community rolling action plan
EUAN EU Agencies Network
CSS Chemicals Strategy for
EUCLEF European Chemicals Legislation
Sustainability of the Commission
Finder
DG DIGIT Directorate General for
EUON European Union Observatory for
Informatics
Nanomaterials
DG EMPL Directorate General for
EU-OSHA European Agency for Safety and
Employment, Social Affairs and
Health at Work
Inclusion
Forum Forum for Exchange of
DG GROW Directorate General for Internal
Information on Enforcement
Market, Industry,
Entrepreneurship and SMEs FTE Full-time equivalent
DG NEAR Directorate General for FWC Framework contract
Neighbourhood and Enlargement Groupe Interinstitutionnel de
GIME
Negotiations Management Environnemental
DG RTD Directorate General for Research (Interinstitutional Group for
6
Annual Report 2024
Acronym Description Acronym Description
Environmental Management) Risks of Chemicals
GLP Good Laboratory Practice PBT Persistent, bioaccumulative and
toxic
GN EUAN Greening Network
PCN Poison Centre Notifications
GPP Green Public Procurement
PDN Performance Development
HelpNet Network of national BPR, CLP and
Network
REACH helpdesks
PFAS Per- and polyfluoroalkyl
HR Human resources
substances
IAC Internal Audit Capability of ECHA
PFCA Perfluorocarboxylic acids
IAS Internal Audit Service of the
PIC Rotterdam Convention on the
Commission
prior informed consent procedure
ICT Information communications (and the respective Regulation)
technology
PMT Persistent, mobile and toxic
IED Industrial Emissions Directive
POP Persistent organic pollutant
2010/75/EU
POPRC Persistent Organic Pollutants
IMS Integrated Management System
Review Committee
IPA Instrument for Pre-Accession
POPs Persistent organic pollutants (and
Assistance
the respective Regulation)
IRS Integrated Regulatory Strategy
PPORD Product and Process Oriented
ISO International Organisation for Research and Development
Standardisation
PPP Plant protection products
IT Information technology
QSAR Quantitative Structure-Activity
IUCLID International Uniform Chemical Relationship
Information Database
R4BP Register for Biocidal Products
JEAP Joint Evaluation Action Plan
RAC Committee for Risk Assessment
JRC Joint Research Centre
REACH Registration, evaluation,
KPI Key Performance Indicators authorisation and restriction of
Management Board chemicals (and the respective
MB
Regulation)
MCCP Medium-chain chlorinated
paraffins REACH-IT Central IT system providing
support for REACH
MS Member State
REF REACH-EN-FORCE (Forum-
MSC Member State Committee coordinated REACH enforcement
MSCA Member State competent project)
authority Rules of Procedure
RoP
NAM New approach methodologies Serious Cross-Borders Threats to
SCBTH
NGO Non-governmental organization Health
NEA National enforcement authority SCIP Database for information on
Substances of Concern In articles
NeRSAP Network of REACH SEA and as such or in complex objects
Analysis of Alternatives (Products)
practitioners
SEAC Committee Socio-economic
OECD Organisation for Economic Co- Analysis Committee
operation and Development
SEV Substance Evaluation
OEL Occupational exposure limit
SLA Service Level Agreement
OHT OECD Harmonised Template
Small and medium-sized
OSOA One Substance, One Assessment SME enterprises
PAH Polycyclic aromatic hydrocarbons Seconded national expert
SNE
PARC Partnership for the Assessment of
SPC Summary of product
7
Annual Report 2024
Acronym Description
characteristics
SVHC Substance of very high concern
Surveys on Willingness-to-Pay to
SWACHE Avoid Negative Chemicals-
Related Health Effects
TA Temporary agent
UNEP United Nations Environment
Programme
UFI Unique Formula Identifier
UN GHS United Nations Globally
Harmonised System of
classification and labelling of
chemicals
UWWT Urban Wastewater Treatment
Directive 91/271/EEC
vPvB Very persistent and very
bioaccumulative
vPvM Very persistent and very mobile
8
Annual Report 2024
Management Board analysis and
assessment
The Management Board welcomes the Annual Report 2024, fulfilling the requirements of the
REACH Regulation (General Report) 1 and those of the ECHA Financial Regulation (Consolidated
Annual Activity Report) 2.
We consider that this report provides a comprehensive account of the activities carried out by
ECHA during 2024, the performance of the Agency against the expected inputs, outputs and
outcomes defined in the Single Programming Document 2024-2026 3. It also represents a fair
overview of the evolution of ECHA’s budget, staffing, management, and its internal management
system strategy and framework.
This assessment is based on our analysis of all parts of the report, including the activities carried
out, achievements, financial information, results of audits, retrospective evaluations, and the
assessment of the internal control system, as well as the risks related to ECHA’s activities
together with the corresponding mitigating measures.
Achievements of the year
2024 was the first year of implementing the ECHA Strategy 2024-2028. We consider that the
performance and quality of the outputs in 2024 were high, as shown in Part I of the Annual
Report.
In assessing 4 the Consolidated Annual Activity Report of the Authorising Officer for 2024, we:
1. Acknowledge the performance of the ECHA committees in delivering opinions to the
Commission, and note, in this context, the enhanced Member State focus on increasing
the capacity of the Committees. RAC and SEAC have made steady progress in the
complex PFAS restriction assessment, with clear updates provided to interested parties
throughout the process
2. Welcome the conclusion of the Joint Evaluation Action Plan and the review and new
objectives of the Integrated Regulatory Strategy (IRS), shifting the focus towards moving
substances to risk management.
3. Welcome the continued outreach efforts to Member States, including via bilateral
engagements of the Executive Director, and the organisation of a meeting of Heads of
Chemical Authorities.
4. Note the 5-year IT transformation plan and the ongoing review of the data management
approach, including a data governance model and look forward to receiving information
about their implementation and about the overall IT preparation to onboard new tasks.
5. Acknowledge the launch of the first version of the ECHA Chem portal, the new system for
making information on chemicals publicly available and encourage the secretariat to
develop it further.
Based on the periodical reporting and the Annual Report 2024 prepared by the secretariat, the
1
Article 78(a) of the REACH Regulation.
2
Article 48 of ECHA’s Financial Regulation.
3
https://echa.europa.eu/documents/10162/58005821/final_mb_31_2023_echa_spd_2024-
2026_en.pdf/49a5ffa2-10e8-327b-b1d4-743758851514?t=1706552312333
4
Assessment pursuant to Article 48(1) of the Agency’s Financial Regulation.
9
Annual Report 2024
Board makes the following observations:
1. ECHA continued preparing for the full implementation of the Drinking Water Directive,
however, the implementation of the provisions for notification and application systems
have been delayed by one year by the legislator.
2. The committee's capacities and competence remain a point of great concern, especially
regarding the implementation of new tasks.
3. ECHA continued preparing opinions on the approval and renewal of biocidal active
substances and Union authorisations of biocidal products. However, the progress with the
Review Programme of existing active substances continued to be limited. The overall
progress of the Review Programme is now at 50%.
4. ECHA continued to provide support to the Forum, including by training a higher than
estimated number of national trainers and inspectors, which is important for the
continued improvement of harmonised enforcement of chemicals legislation across the
EU.
Management
• The 10 recommendations the Management Board provided for 2024 as part of the
assessment of the 2023 Annual Report have been implemented or are in progress.
• 178 outputs were delivered out of the planned 200. The challenges in delivering some of
the outputs were mostly related to lack of external input, revised timing of legislative
proposals, technical or resourcing issues and the need for task reprioritisation.
Budgetary and financial management
• We welcome the excellent performance of ECHA in implementing its budget with 99.5%
of commitment rate and 0.5% of cancelled payment appropriation rate, with processing
99.8% of payments within legal deadlines, while keeping the strict segregation between
its funding sources and operating in an environment of fluctuating and challenging to
predict fee income.
Human resources management
• We commend ECHA for having maintained a high rate of filling its establishment plan
posts (97.2%) and the strong focus on staff wellbeing, diversity and inclusion.
• We note the gender imbalance (30% female, 70% male) at the middle and senior
management levels.
• We welcome that ECHA adopted and started to implement the People and Organisational
Strategy 2024-2028.
• We take note of the outcome of the Retrospective evaluation of ECHA’s HR strategy 2019-
2023, including that ECHA compares with other ENVI agencies as the Agency with the
lowest proportion of its HR staff to total staff and the lowest proportion of “neutral staff”
to total staff, which includes posts in horizontal services, such as finance, procurement,
quality management, linguistics etc.
Audit and retrospective evaluation results and follow-up on recommendations
10
Annual Report 2024
• Assurance has been provided by the Internal Audit Capability (IAC) on audits, follow-up
audits and the implementation of the recommendations, as well as appropriate
information from the secretariat on the retrospective evaluations. The audits and
evaluations planned for 2024 were all completed.
• The European Court of Auditors adopted a positive opinion regarding the 2023 annual
accounts, with no reservation or observation. We welcome that there are no pending
observations or recommendations.
• The European Parliament, as the Discharge Authority, granted discharge to the Executive
Director with respect to ECHA’s 2022 budget, including the decision on the closure of the
2022 accounts. The secretariat duly provided replies to the Discharge Authority’s
observations and the implementation of the six recommendations is on track.
• The Internal Audit Service (IAS) of the Commission did not conduct any audit in ECHA in
2024. There are no pending recommendations from past IAS audits.
Internal control framework and Integrated Management System
• We consider that the internal control framework remains effective and functioning.
• ECHA’s Integrated Management System Strategy and Framework has demonstrated its
effectiveness in achieving the Agency’s strategic goals and priorities in 2024.
• ECHA obtained recertification of the Agency’s International Organisation for
Standardisation (ISO) 9001:2015 and 14001:2015 and EU Eco-Management and Audit
Scheme (EMAS). Guidelines for the implementation of the ISO 20121:2012 standard on
event sustainability management systems were developed and issued during 2024.
Organisational risk management
• We highlight the importance of the continued development and application of the
organisational Risk Management Policy, including via training and awareness raising.
• We found the regular updates on the risk register, including the continued specific
reporting on the IT-security related risks, pertinent.
• We note that appropriate measures are in place to identify, monitor and manage risks
threatening the achievement of ECHA’s objectives. The secretariat regularly signalled
significant risks and control issues to the Management Board, including as part of the
Executive Director reporting, as well as the updates to the Agency Risk Register.
• We welcome the investments and efforts to meet cybersecurity regulation 5 requirements,
and we note the low number of cybersecurity incidents. We call for continued focus on
this area.
Management Assurance
The Management Board takes note of the systems in place to support the Executive Director’s
declaration of assurance and takes note of the declaration of assurance of the Executive Director.
Based on the information in the Section II, no significant weaknesses or gaps that may threaten
the achievement of ECHA’s objectives were identified.
5
Regulation (EU, Euratom) 2023/2841.
11
Annual Report 2024
The Board takes note of the fact that no reservations were made.
Recommendations for the secretariat for 2025
Based on our assessment, the Management Board requests particular emphasis in 2025 on the
following actions, without prejudice to the implementation of the Single Programming Document
2025-2027:
1. Take appropriate actions to maintain the committees’ ability to deliver transparent,
independent and high-quality scientific outputs for existing and new tasks: Continue
supporting the work of the committees to further enhance the Committees competence
and working structures including increasing their capacity. In this context, keep in focus
the continued facilitation of the preparation of the RAC/SEAC opinion on the UPFAS
dossier.
2. Continue closely following the legislative process concerning ECHA’s new tasks and
support the decision-makers with technical-scientific input, as required. Prepare for the
implementation of new tasks, according to the (timing of) availability of resources and
timely signal issues and risks to the Management Board.
3. Maintain focus on engaging and building trusted relationships with key European
institutional stakeholders, as well as with Member State partners and engage with other
stakeholders. Continue providing clear and accessible information about ECHA’s mandate
and chemical safety to all stakeholders.
4. Continue the support to Member States competent authorities for biocidal products, with
a view to accelerating the progress with the Review Programme of existing active
substances.
5. Fine-tune the activity-based budgeting of the Agency as it will be crucial in the future
against the background of tasks assigned to the Agency deriving from many pieces of
legislation.
6. Update the Management Board on the actions implemented in follow up to the
organisational review of ECHA, given its importance in addressing the evolving nature
and increasing complexity of ECHA’s tasks and mandate.
7. Implement the refocused IRS objectives: maintain a good knowledge about the chemicals
in ECHA’s databases and shift the focus to deliver risk management outcomes for (groups
of) substances.
8. Continue supporting the implementation of the revised CLP regulation, including for the
introduction of new hazard classes, grouping and read-across approaches, including in
the run-up to the first implementation deadline.
Acknowledgments
The members of the Management Board express their appreciation to ECHA staff, members of
ECHA bodies and the Agency’s partners, in particular Member States, for their commitment and
achievements in 2024.
Conclusion
In assessing the Annual Report 2024, the Management Board concludes that the overall
performance of ECHA is in line with the objectives included in the Agency’s Single Programming
12
Annual Report 2024
Document 2024-2026 and ECHA made good progress in delivering its Strategy 2024-2028.
Based on the above observations, the Management Board requests that the Annual Report 2024
be forwarded to the Member States, the Court of Auditors, the Commission, the European
Parliament, the European Economic and Social Committee and the Council.
13
Annual Report 2024
I am pleased to present the Agency’s annual report for
Foreword 2024, the first under our Strategy Statement 2024-2028.
We delivered the legal mandate across the wide range of
chemical legislation under our remit and met the
objectives of our work programme 2024.
With our goal to be a trusted chemicals agency, we
continued our commitment to delivering transparent,
independent, and high-quality scientific advice, opinions,
and decisions across REACH, CLP, Biocides and other
legislative areas. In all legislative areas, we also delivered
significant levels of support and advice to the Commission,
Member States, industry and other stakeholders.
The members of our scientific committees are central to
our ability to deliver opinions and decisions. In this regard,
having the appropriate capacity and competence within
our committees is essential. We have put more focus on
Dr Sharon McGuinness increasing capacity in relation to the Risk Assessment
Committee (RAC) and the Socio-Economic Analysis
Executive Director Committee (SEAC). This focus included engaging with
Member States with a view to increasing nominations as
well as measures, such as revised remuneration for
specific tasks. Together with the Commission, ECHA also
wrote to Member State authorities asking them to
nominate, as applicable, the two experts to the scientific
committees. Having full capacity of our committees is not
only important for current tasks under REACH and CLP, but
also for new tasks such as drinking water and batteries.
We have seen increased Member State focus on ensuring
capacity for our committees and ended the year with 80%
membership in RAC and 55% in SEAC. To ensure our
committees are sustainable in the future, ECHA also
contributed to the Commission’s preparatory work to
strengthen governance and streamline operations with the
future ECHA Basic Regulation, and we look forward to
seeing a proposal in 2025.
In 2024, we completed reviews of the Integrated
Regulatory Strategy (IRS) and the Joint Evaluation Action
Plan (JEAP), which were two significant initiatives under
our 2018-2023 strategic plan. As a result of these reviews,
we have concluded the Joint Evaluation Action Plan and
revised the Integrated Regulatory Strategy. The findings
and recommendations arising from these reviews will
inform our future focus on risk management activities.
Throughout the year, we prepared for implementation of
new or changing legislative tasks. We commenced
implementing legislation tasks in relation to Drinking
Water, Batteries, Serious Cross Border Threats to Health
and Industrial Emissions. In anticipation of the publication
of the revised CLP Regulation, we updated and published
the tools and the CLP guidance on criteria for new hazard
classes. We also supported the Commission in relation to
14
Annual Report 2024
their work on the various legislative packages under One Substance, One Assessment (OSOA)
as it made its way through the co-decision process.
We also continued delivering on our legal obligations under the Biocidal Products Regulation
(BPR), however, the low number of completed assessment reports for biocidal active substances
submitted by Member States continued. We remain committed to working together with the
Member States and the Commission to address this issue with the Review Programme for
existing active substances.
Communicating and engaging with all stakeholders, EU institutions, EU agencies, Member
States, industry and other stakeholders is necessary to deliver our legal mandate and our vision
of chemical safety through science, collaboration and knowledge. In 2024, we put increased
emphasis on these areas. We also worked closely with other EU Agencies, including the
European Medicines Agency (EMA), the European Food Safety Authority (EFSA), the European
Environment Agency (EEA) and the European Centre for Disease Control (ECDC). This work
included signing the One Health Framework of action between our agencies. This collaborative
work is important for delivering existing tasks and will become even more important as we
implement the future tasks under the OSOA approach.
With our new strategic priority to support SMEs, we prepared an engagement plan which we will
implement in the coming years. To increase awareness and transparency of the chemicals data
we have and make it widely available to industry and interested parties, we launched a new
dissemination tool, ECHA CHEM and will continue to increase information available on it over the
coming years.
Delivering our current and future legal mandate and our strategic vision and goals requires an
organisation that has the necessary people and systems in place to meet increasing demands
and expectations. In 2024, we took steps to ensure our organisation, our data and IT will all be
fit for the future. On IT, we finalised a 5-year IT transformation plan, which foresees four portals
based on the specific tasks and needs of different groups – industry, authorities, ECHA and the
public – built on modular enterprise architecture. Coupled with this IT focus, we are also
reviewing our approach on data management, with the first step taken in 2024 to confirm a data
governance model.
In line with ECHA’s priority to ‘Ensure that our organisational model is ready to support delivery
of our current and future mandate’, ECHA undertook an organisational review in 2024. The
organisational review was conducted to address the evolving nature and increasing complexity
of ECHA’s tasks and mandate and meet our strategic goals and vision. The recommendations,
which addressed ways of working, strategic prioritisation and organisational structure will be
addressed in 2025.
I would like, in conclusion, to express my thanks to the Management Board for their support and
collaboration throughout the course of 2024. A particular note of thanks and appreciation also
to ECHA’s management team and all the staff for their dedication and commitment in delivering
our 2024 Work Programme.
15
Annual Report 2024
Executive summary
ECHA’s achievements in 2024 reflect a strong commitment to our strategic goals and priorities,
as well as our vision of chemical safety through science, collaboration and knowledge. We
continued to progress and implement our existing legal mandate and also commenced
implementation of several new tasks. Our role continues to expand, and in 2024, we supported
decision makers as they prepared for the introduction of further new regulatory tasks for the
Agency. Throughout the year, we collaborated closely with our many stakeholders, including
Member States, the Commission, EU agencies, industry and NGOs. This engagement ensures we
can deliver transparent, independent and high-quality scientific opinions and decisions and
ensure duty holders meet their legal obligations. While much has been achieved in 2024, the
Agency continues to face challenges, which will need to be addressed over the coming period.
However, we also took steps to address how the Agency can tackle several of these challenges
by modifying our ways or working in the future.
Strategic Goal - a Trusted Chemicals Agency
As the EU Chemicals Agency, we work continuously to be trusted and reliable as we implement
chemical regulations and protect health and the environment through our work on chemical
safety. A key priority for the Agency is to deliver transparent, independent and high-quality
scientific opinions and decisions as required under our legal mandate. Under REACH and CLP,
our committees delivered opinions to the Commission on applications for authorisation of 55
uses of substances, a restriction proposal on creosote, as well as adopting 56 opinions on
harmonised classification and labelling proposals. We also added two entries to the Candidate
List, bringing the total to 242 entries in the end of 2024 6. Also under REACH, we published the
investigation report on brominated flame retardants and continued to make progress on the
PFAS restriction opinion making throughout the year.
Following the introduction of the revised CLP Regulation, we updated and published guidance to
include the new hazard classes. This updated guidance was a significant collaborative
achievement by experts from ECHA, Member States, industry and non-governmental
organisations.
In relation to biocides, we submitted to the Commission 15 opinions on active substances, 17
opinions on Union authorisations along with 20 opinions on administrative changes of a Union
Authorisation, 15 opinions on same biocidal products of a Union Authorisation and eight opinions
on classification of changes of biocidal products.
In other legislative tasks, we delivered four opinions on Occupational Exposure Limits (OELs)
and updated the draft scientific dossier (Annex D POPS proposal) for
Octamethylcyclotetrasiloxane (D4), Decamethylcyclopentasiloxane (D5) and
Dodecamethylcyclohexasiloxane (D6) based on new available information. We also conducted a
screening exercise to identify substances that could meet the POP criteria, with the aim of
identifying a new candidate for an EU proposal.
As we aim to enhance decision and policy making through optimal use of data, we initiated the
implementation of our new data management approach and established a Data Governance
Office to manage and oversee all our regulatory data. We also took measures, such as initiating
a new Chemical Identifiers Management System to manage the inherent differences between
regulatory contexts and prepare the Agency to onboard new tasks. Early in 2024, we launched
the ECHA CHEM platform, which enables public access to critical chemical safety information.
6
Five additional entries were added in January 2025, bringing the current total to 247 entries.
16
Annual Report 2024
The Integrated Regulatory Strategy, which was a cornerstone of our strategic efforts from 2019
to 2023 was reviewed, as was the Joint Evaluation Action Plan. These reviews were completed
as we prepared for a new phase in future REACH evaluation and risk management activities. Key
drivers for IRS in the future will be to maintain a good knowledge about the chemicals in our
databases and shift the focus to delivering risk management outcomes for (groups of)
substances. In 2024, we concluded the systematic screening of high production volume
chemicals, marking the culmination of the previous five year’s IRS work. We successfully
concluded the actions under the Joint Evaluation Action Plan and refocussed our efforts away
from compliance checks to conclude follow-up of dossiers after draft decisions on compliance
checks.
Strategic Goal - Respond to Emerging Challenges and Changes in Our Legal Landscape
In 2024, we demonstrated our agility in addressing emerging challenges and legislative changes.
We continued the planning and implementation of new tasks that have arrived at the Agency
in recent years, such as Batteries, Drinking Water Directive and Serious Cross Border Threats to
Health. Preparations were carried out on relevant aspects such as technical, scientific and
stakeholder engagement. In addition to ensuring the Agency is ready for these new tasks, we
also must ensure that our scientific committees, Risk Assessment Committee (RAC) and Socio-
Economic Analysis Committee (SEAC) are preparing. In the case of the Drinking Water Directive,
a RAC Working Group has been established, and work is progressing on developing procedures
for dealing with applications in the future. We commenced developments in our IT systems to
be able to deal with future tasks under the DWD. In this context, we have agreed that IT
development for the DWD will be the pilot for our future IT systems. In delivering these new
tasks, we need to engage with many new stakeholders and throughout the year, we held several
workshops and meetings with them.
In support of the Chemicals Strategy for Sustainability (CSS), we provided support and inputs
to the Council, European Parliament and Commission in relation to the Commission legislative
proposal on One Substance One Assessment (OSOA). This proposal will see several regulatory
tasks be reattributed to ECHA as well as the introduction of a Common Data Platform, where the
Agency will play a lead role. We developed, as required under the CSS and the mandate of the
8th Environmental Action Programme, an indicator framework for chemicals with EEA and the
Commission and produced a joint synthesis report on this framework with EEA.
Strategic Goal - Communicate and Engage
Efforts to improve communication and engagement with stakeholders were central to our
operations in 2024. A widely attended ECHA conference was organised, as well as a meeting of
Member States' Heads of Chemicals Authorities. We launched a new External Communications
Strategy and Stakeholder Engagement Approach to foster stronger relationships with Member
States, industry, and stakeholders representing workers, the public and the environment. This
includes clearer messaging on chemical risks, regulatory processes, and upcoming legislative
changes. An action plan was agreed to step up our efforts to support SMEs and will be
implemented over the next years. The number of followers across ECHA's social media channels
continued to grow (by 21%, to over 130 000 in 2024), as well as our website visitors, growing
by over a million in 2024 to almost 5.5 million.
We further strengthened our collaboration with peer agencies (EFSA, EMA, EEA and ECDC),
including by conducting joint initiatives in scientific-technical areas and institutional engagement.
We signed the One Health framework of action with these agencies and presented our work to
the Environment Committee of the European Parliament. To further ensure consistency in our
methodologies, we delivered jointly with EFSA a guidance on risk assessment on bees from the
use of biocides, and cooperated with EFSA, EMA and ECDC on a report to address anti-fungal
resistance, that was endorsed by the BPC. The IUCLID platform cooperation with EFSA on Plant
Protection Products continued in 2024, with the agreement to start expanding IUCLID for Food
Contact Materials.
17
Annual Report 2024
Strategic Goal - Lead on Chemical Knowledge and Expertise
We continued our commitment on promoting New Approach Methodologies (NAMs) in 2024
through a range of measures. For example, we contracted a collaborative consortium of
researchers to conduct scientific studies on the reliability and relevance of NAMs as alternatives
to animal testing and to promote the use of such methods in the future. The contract will run for
six years and has a total value of EUR 4.2 million in funding. These projects will investigate the
application of omics in regulatory contexts to enhance read-across and grouping methodologies;
explore potential alternatives to current aquatic toxicity testing involving the use of fish; and
examine the use of in vitro toxicokinetics to support hazard assessment. We further
strengthened our interactions with stakeholders and EU Agencies and worked closely with the
European Commission to support development of a roadmap to phase out animal testing.
We proactively contributed to expanding scientific and technical competence and knowledge on
chemical safety through our work in PARC (Partnership for the Assessment of Risks from
Chemicals). A key achievement in relation to PARC has been the publication of our updated
report on Key Areas of Regulatory Challenge, which provides details on research needs on
chemical safety.
In support of the Commission’s international efforts, we participated in a wide range of OECD
(Organisation for Economic Co-operation and Development) activities, ranging from
development of non-animal methods to completing the development of the QSAR toolbox. We
also supported the Commission in the UN Sub-Committee of Experts on the Globally Harmonised
System for Classification and Labelling of Chemicals (GHS). We delivered support to pre-
candidate countries and hosted several IPA countries in meetings and trainings in capacity
building efforts on communication and enforcement.
Strategic goal - Invest in Our People and Organisational Excellence
We continued the focus on investing in our people and organisational development through
implementing actions under our People and Organisational Strategy 2024-2028, our Wellbeing
Action Plan and our Diversity and Inclusion Action Plan. At the end of 2024, our staffing plan
was filled at 97.2%. A review of ECHA’s organisation was completed to take account of the new
strategy and our expanding legal mandate. The recommendations, which addressed ways of
working, strategic prioritisation and organisational structure will be addressed in 2025.
We initiated a pilot on optimising use of our office building and conference centre, to plan and
test new ways of working. In 2024, we continued to successfully organise meeting services for
approximately 400 events and official meetings, with 36 600 participants joining online and a
further 5 300 visitors in person.
We effectively managed our financing through close monitoring of uncertain fee income
development. On the final budget size of EUR 126.6 million, the Agency reached a 99.5%
commitment rate and 87.0% payment rate, exceeding the targets set. The European Court of
Auditors gave a clean audit opinion on ECHA's annual accounts for 2023.
The ongoing transformation of our IT infrastructure and data management systems further
exemplifies our commitment to enhancing ECHA's organisational excellence. A five-year IT vision
and plan was agreed and implementation commenced with the IT systems needed for the
Drinking Water Directive, which will be the first to be considered under our new approach. As
part of our continued efforts to improve and innovate, we have also established a horizontal
working group on Artificial Intelligence (AI). This group has created guidelines for the safe use
of AI, assessed several use cases and proposed several pilots, which will be commenced in 2025.
18
Annual Report 2024
Current and future challenges
Notwithstanding all our achievements and successes in 2024, there are still areas where the
Agency has challenges now and in the future.
The first such challenge is in relation to the sustainability and workability of our scientific
committees, the RAC and SEAC. Although these committees have delivered significant levels of
opinions in 2024, with the continued work required to meet existing tasks, such as concluding
the PFAS dossier as well as prepare for new tasks under the DWD and harmonised classifications
of new hazards (endocrine disruptors etc), they continue to be under pressure. Efforts have been
taken by the secretariat and the Management Board to address workability. For example, this
year, the MB agreed to increase the payments for REACH restriction rapporteur work in RAC and
SEAC. Through active engagement with Member States throughout the year, there has been an
increase in numbers of nominations, and we ended the year with 80% membership in RAC and
55% in SEAC. While this is welcomed, Member States are still asked to nominate the full number
of experts to the committees. It is hoped that the Commission proposal for an ECHA Basic
Regulation, which is planned for 2025, will introduce measures to address workability and
sustainability of the committees. However, as such measures are unlikely to be in place for
several years, interim measures will be needed if the committees are to meet new tasks on DWD
from 2026 onwards. The Agency, together with the Commission and Member States, will
continue to review the work of the Committees to ensure that it can meet its existing and future
tasks.
The significant work on the PFAS dossier has also put pressure on our committees during 2024
and the Agency has taken steps to provide additional supports to the Rapporteurs and will
continue to do so until the opinion making is concluded. We have also added additional resources
in the Secretariat Ensuring the integrity of the opinion making process so that we can deliver a
final opinion that is independent, transparent and of high-quality, was and will remain the
Agency’s main focus.
Since 2019, the Agency has focussed on the compliance check process, which has meant that
there are backlogs in other areas of dossier evaluation. With the conclusion of the Joint
Evaluation Action Plan, the focus has now shifted to conclude follow-up of dossiers after draft
decisions on compliance checks as well as examining testing proposals. With this change of
focus, we aim to reduce the backlogs over the coming period. Support from the Commission,
Member States and registrants will be important in helping us address this matter.
After a peak number of applications for authorisation in the past years, mainly for the use of
hexavalent chromium substances, the number of applications significantly decreased in 2024,
with 43 applications and review reports received (covering 57 uses). As the total number of
applications received has been higher than the capacity of the scientific committees, they
continue to work steadily to process the applications in their opinion making. In line with the
Commission approach to address the high levels of authorisation applications for hexavalent
chromium substances, ECHA progressed the development of a restriction proposal on hexavalent
chromium, for which the assessment in the committees will start in 2025. However, until such
time as a restriction proposal on these substances is agreed and enters info force, ECHA will
have to continue to prioritise applications in line with the capacity of the committees.
We also continued delivering on our legal obligations under the Biocidal Products Regulation,
however, the low number of completed assessment reports for biocidal active substances
submitted by Member States continued. We remain committed to working together with the
Member States and the Commission to address this issue with the Review Programme for
existing active substances.
19
Annual Report 2024
While every effort is being made to prepare in advance for implementing new tasks, challenges
remain as resources for new tasks will usually only be made available to ECHA when the
legislative proposal is finalised. As many of the new tasks, requires significant preparatory work
from IT systems development to committee procedures to stakeholder guidance and support,
the Agency has to complete its preparations in sometimes very short timeframes. Prioritisation
of our preparatory work may have impacts on existing tasks, though the Agency will seek to
keep such impacts to a minimum.
Finally, as the Agency mandate expands and as technology rapidly evolves, the Agency needs
to ensure its IT and data management systems are modernised and user focussed. The
development of the Agency’s long term IT vision and plan is a step in the right direction;
however, it will require intense activity and resources over the coming period to ensure we are
ready to meet new tasks such as Drinking Water as well as meet stakeholder expectations and
demands. The Agency will use the organisational review recommendations to address these
challenges where possible. However, to fully address all our challenges, ECHA will need inputs
from external parties such as the Commission, Member States and stakeholders.
20
Annual Report 2024
Part I. Achievements of the year
Dossier preparation 7
Objective 1: Companies supported on inquiries and data sharing.
Main Outputs Execution Status
Inquiries and disputes on data We successfully handled inquiries and Yes
sharing are handled in line with legal disputes over data sharing according to legal
requirements and timelines. requirements and timelines, ensuring a
smooth process for all parties involved. We
managed a record number of inquiries, with a
14% increase compared to previous years,
and ensured that the process ran smoothly.
We also continued to support companies with
the tools and guidance they need to
successfully register and update their
information.
Indicators Estimate Actual
Inquiries received and concluded 4 800 5491
Objective 2: Harmonised IT tools are available to support the transparent sharing of harmonised
data between industry and regulatory authorities.
Main Outputs Execution Status
Promotion of IUCLID as the We hosted, for the first time, a joint meeting Yes
international harmonised format for with OECD on IUCLID and the eChemPortal.
chemical data continued. As more international authorities adopt
IUCLID as the reference implementation of
the OECD Harmonised Templates 8 (OHTs),
there is a greater need to monitor and review
how IUCLID data is being exchanged and
made available for publication. This joint
meeting contributed to better understanding
of how to best manage our data and tools
globally (OECD) and take stock of the
challenges faced internationally in exchanging
and managing data.
IUCLID updated to incorporate We made important updates to the Yes
existing, new and changing International Uniform Chemical Information
regulatory requirements. Database (IUCLID) to meet new EU and
international regulatory requirements. This
7
This section covers only REACH registration dossier preparation. The support to the preparation of other REACH and
CLP dossiers are covered by the relevant sections.
8
https://www.oecd.org/en/topics/sub-issues/assessment-of-chemicals/harmonised-
templates.html#:~:text=The%20OECD%20Harmonised%20Templates%20(OHTs)%20are
21
Annual Report 2024
included new formats, validation, and filtering
rules to make sure the database stays aligned
with different regulatory needs.
IUCLID progressively updated to We updated IUCLID as required and also Yes
support the needs of OECD and promoted it as the standard for chemical data
international partners. worldwide.
Scientific contribution made to We contributed to development of the OECD Yes
development of the OECD test guideline programmes in key areas by
harmonised test guidelines relevant actively participating in the expert group
for the EU information meetings and consultations.
requirements.
Indicators
N/A
Dossier submission and processing
Objective 1: Access to market for duty holders continues to be streamlined and predictable.
Main Outputs Execution Status
REACH registration dossiers (initial We ensured the timely processing of all Yes
and updates) processed. dossiers submitted by industry under REACH
and CLP. In 2024, we saw a significant
increase in C&L notifications compared to the
previous year, far exceeding our initial
estimate. This surge was primarily driven by
a few companies, submitting large volumes of
notifications, and/or using system-to-system
submission.
PPORD notifications processed, and PPORD notifications were monitored and Yes
data analysed to identify and analysed to track innovation trends and new
monitor innovation and new chemical developments.
chemicals trends.
Completeness checks including All submitted registrations were completeness Yes
manual verifications performed, checked, with one third undergoing manual
invoices issued, and confidentiality checks. In 2024, fewer dossiers were
requests assessed. submitted than expected, and the submitted
data was more complete than in previous
years. As a result, the actual number of
registrations failing the first technical
completeness check was significantly lower
than estimated based on previous years, with
669 failures compared to the expected 1 300.
An appeal on a completeness check decision
was dismissed, reinforcing ECHA’s
implementation approach, which includes
manual checks of part of the information.
Clear and timely feedback provided We updated the dossier preparation manuals Yes
to companies on how to successfully and reviewed failure messages to further
22
Annual Report 2024
complete their submissions. improve the support to companies that submit
information to ECHA.
The verification of the size of SME ECHA performed over 400 companies size Yes
companies which registered after verifications and reduced delays between
the last registration deadline submission and verification to further
continued and the time lag between streamline the process. We also provided
submission and beginning of the input to the European Commission to shift
verification further reduced. SME verification to an “ex-ante” approach,
which will enhance process predictability and
efficiency.
Tools and processes for invalidation ECHA developed tools and procedures to Yes
of registrations developed further address various invalidation scenarios,
for different circumstances, such as including invalidation of registrations and
the implementation of EU sanctions. implementation of EU sanctions. For the
revocation of non-existing companies and the
invalidation process, we improved the
process, gaining efficiency and ensuring
consistency.
Preparations commenced, as The Commission’s work on revising the REACH No
necessary, for the adaptations Regulation is ongoing. ECHA anticipates a
stemming from the revision of the proposal for a revised Regulation in 2025 and
REACH Regulation. will work closely with the Commission to
provide input and support the development
and implementation of the proposal.
Indicators Estimate Actual
Number of PPORD notifications received 240 238
Number of C&L notifications received 35 000 168990
Number of Registration dossiers received (incl. updates) 15 000 13 470
Number of SME companies verified for their status 400 408
Registrations stopped for manual verification at technical 5 100 4 206
completeness check
Number of registrations failing first technical completeness check 1 300 669
Number of confidentiality assessments concluded 220 241
Number of revocations or invalidations concluded 150 126
Objective 2: Submission activities are user-focussed, streamlined and adaptable.
Main Outputs Execution Status
ECHA’s submission systems Progress was made on how to simplify the Yes
transformation plan commenced. systems used by companies to submit their
dossiers towards an Industry portal that will
offer a single-entry point with increased user-
friendliness and consistency. We initiated this
transformation plan by focusing on drinking
water submissions under DWD.
23
Annual Report 2024
Indicators
N/A
Identification and prioritisation of substances and groups of
substances
Objective 1: Prioritisation of regulatory action on individual substance and/or groups of
substances.
Main Outputs Execution Status
Workshop organised with the We discussed and developed new objectives Yes
Member States and stakeholders to for the IRS in conjunction with the
review the Integrated Regulatory Commission and Member States to ensure that
Strategy and actions on the the approach meets current and future
coordinated identification and challenges. Key drivers for the IRS in the future
prioritisation of substances and include the need to maintain a good knowledge
groups of substances identified. about the chemicals in our databases and
shifting the focus to deliver risk management
outcomes for (groups of) substances.
We also continued strengthening co-operation
across regulatory frameworks and with sister
agencies, especially EFSA and more recently
EMA, as this is essential to support
information sharing and consistency of
regulatory outcomes. We explored synergies
between collaboration platforms such as
RIME+ and the ‘One substance, one
assessment framework’.
Groups of substances identified for We supported authorities in identifying Yes
authorities to select for CLH and (groups of) substances that require risk
restriction processes. management through shortlisting (groups of)
substances considered as good candidates for
CLH, restriction, or other risk management
options. CLH cases were short-listed and
presented to Member States at the RiME+
meetings.
Results from the group assessment We identified candidates for the Restrictions Yes
reports, on request of the Roadmap by screening assessment of
Commission, used to update the regulatory needs (ARN) cases. These
restriction roadmap. suggestions were submitted to the
Commission, which incorporated the
proposals into the updated Restrictions
Roadmap.
Progress report on the Integrated In 2024, we concluded the systematic Yes
Regulatory Strategy published. screening of high production volume
chemicals, marking the culmination of a five-
year effort to group and assess nearly all high-
tonnage substances in our database.
We published the final IRS report, which takes
24
Annual Report 2024
stock of the progress achieved over the last five
years and outlines future plans.
Indicators Estimate Actual
Number of groups of substances for which a preliminary conclusion on 40 47
potential regulatory follow up was drawn or further clarified
Evaluation 9
Objective 1: Dossier evaluation is efficient, transparent and scientifically and legally robust.
Main Outputs Execution Status
Follow-up actions to the 2023 review In 2024, we successfully concluded the Joint Yes
of Joint Evaluation Action Plan Evaluation Action Plan (JEAP), which aimed to
completed. A proposal for a new ensure compliance of registration dossiers and
approach to compliance check reviewed the outcomes together with the
developed. Commission, Member States and
stakeholders.
The 2024 annual evaluation targets were met. Yes
Evaluation targets and indicators Collaborative efforts with Member States
delivered. showed strong alignment, with less than 10%
of draft decisions discussed by the Member
State Committee (following proposals for
amendment by Member States). This enabled
a high throughput of cases.
Testing proposals examined within In 2024, testing proposals were not No
the legal deadlines. consistently examined within the legal
deadlines, which apply only to non-phase-in
substances. This was due to prioritising
decisions with a backlog in follow up and
testing proposal evaluations - a focus, which
will persist in the coming years. While
significant efforts were made to address
pending evaluations and follow-up actions,
the focus on backlog reduction meant that
some testing proposals were not processed
within the expected timelines.
To identify challenges in the process, we
performed an audit, which provides insight on
the issues and resulted in several
recommendations, which will be addressed in
2025. The findings and recommendations will
be shared with the Commission and further
analysed to ensure improvements are
implemented effectively.
9
Title VI of Regulation (EC) No 1907/2006
25
Annual Report 2024
Information submitted in response Follow-up actions were conducted to verify Yes
to ECHA evaluation decisions that any updated information provided in
examined without delay and response to evaluation decisions addressed
conclusions communicated to the the requested requirements.
Commission and Member State
competent authorities.
National enforcement authorities We kept national enforcement authorities Yes
informed in case of non-compliance informed in cases of non-compliance with
with the decision and follow-up decisions, and drafted follow-up decisions
decisions drafted where appropriate. where appropriate.
Updated recommendations to We published regular updates to the website Yes
registrants stemming from and communicated recommendations directly
evaluation published and to registrants as needed.
communicated.
Support to the Commission provided The Commission’s work on revising the REACH No
in relation to the CSS and the REACH Regulation is ongoing. ECHA anticipates a
revision (Evaluation and the proposal for a revised Regulation in 2025 and
annexes on information will work closely with the Commission to
requirements). provide input and support the development
and implementation of the proposal.
Targeted study audits requested in We requested two GLP study audits based on Yes
case a concern about compliance concern and three GLP study audits based on
with principles of Good Laboratory random selection.
Practice is identified by ECHA or a
Member State.
Regulatory advice provided to We provided regulatory advice to registrants Yes
registrants and other interested and other interested parties on information
parties on information requirements requirements and the evaluation processes for
and on dossier and substance dossiers and substances through guidance,
evaluation processes. helpdesk and direct interactions with
registrants.
Indicators Estimate Actual
Compliance checks concluded: draft decisions or no action 250 251
Final decisions on dossier evaluation (testing proposals and 250 300
compliance checks)
Number of substances for which a conclusion was reached in the 250 219
follow-up to dossier evaluation
Objective 2: Substance Evaluation by Member States becomes more efficient and effective.
Main Outputs Execution Status
Updates of the CoRAP proposed to The CoRAP list was updated with 25 Yes
the MSC for substances where substances for evaluation by 12 Member
substance evaluation is the most States, and during the year conclusions were
appropriate tool to generate further reached for 19 substances.
hazard information.
26
Annual Report 2024
Member States advised and We provided continuous support to evaluating Yes
supported in achieving substance MSCAs on their open substance evaluation
evaluation conclusions as fast as cases. Based on eMSCAs' feedback, MSCAs
possible. expressed high level of appreciation with this
support.
The appropriate regulatory risk An initial analysis of follow-up regulatory risk Yes
management measures and management measures and initiatives
initiatives adopted by Member proposed by eMSCAs as an outcome of
States. substance evaluation has been conducted and
will be communicated to ECHA stakeholders in
2025. Evaluations during the year led to key
regulatory actions, including harmonised
classification and labelling, identification of
substances of very high concern (SVHC), and
restrictions.
Number of substance evaluation 10 new evaluation cases were opened while Yes
cases currently opened reduced 19 substances evaluation cases were
further. concluded. This led to a c.a. 10% decrease in
the number of open SEV cases in 2024. Eight
substance evaluation decisions (six draft
decisions and three final decisions) were
issued, requesting data to address concerns
regarding endocrine disruption, PBT/vPvB, or
mutagenicity. The number of final decisions
was lower than anticipated, reflecting the gap
between the original ambition of ECHA and
Member State authorities, and the
complexities emerging at the time of
implementation.
Indicators Estimate Actual
Substance evaluation final decisions issued 10 3
Number of substances for which a conclusion was reached in 25 19
substance evaluation
Authorisation 10
Objective 1: Substances of very high concern identified, controlled and progressively replaced.
Main Outputs Execution Status
Substances of very high concern Two entries were added to the Candidate List, Yes
identified and included in the bringing the total in 2024 to 242 entries.
Candidate List. These substances were found to have either
very persistent and very bioaccumulative
properties, or were shown to be persistent,
bioaccumulative and toxic, or displayed
negative effects on reproduction, or had
10
Title VII of Regulation (EC) No 1907/2006
27
Annual Report 2024
endocrine disrupting properties for the
environment. In addition, an existing entry
was updated to reflect that it is an endocrine
disruptor to the environment based both on
its intrinsic properties and when it contains an
impurity at ≥ 0.1% w/w. The total number of
new entries was lower than the initial
estimate, reflecting the gap between the
intentions communicated by the dossier
submitters, and the ability to implement the
dossiers, through the drafting and decision-
making phase, in time.
Applications for authorisation After a peak number of applications for Yes
processed and progressed in line authorisation in the past years, mainly for the
with agreed approach. use of hexavalent chromium substances, the
number of applications significantly decreased
in 2024, with 43 applications and review
reports received (covering 57 uses). As the
total number of applications received has
been higher than the capacity of the scientific
committees, they continue to work steadily to
process the applications in their opinion
making (see objective 2 below).
In 2024, the actual number of downstream
user notifications of authorised uses of SVHCs
provided by companies was lower than
estimated (766 actual compared to 3000
estimated). Estimating a figure for such
notifications is very difficult in any given year,
hence the discrepancy.
Indicators Estimate Actual
Number of new entries in the Candidate List 15 2 11
Applications and review reports for authorisation received (number of 40-60 57
uses)
Number of downstream user notifications of authorised uses of SVHCs 3 000 766
Objective 2: Opinions of the Committees for Risk Assessment (RAC) and Socio-Economic
Analysis (SEAC) are timely and fit-for purpose.
Main Outputs Execution Status
Opinions on applications for The scientific Committee for Risk Assessment Yes
authorisation delivered to (RAC) and the Committee for Socio-Economic
Commission. Analysis (SEAC) delivered opinions on
applications for authorisation of 55 uses of
substances.
11
See respective output above.
28
Annual Report 2024
Participation in workshops and We actively participated in key networks and Yes
network meetings facilitated as meetings such as the Network of REACH SEA
necessary, to develop and Analysis of Alternatives Practitioners
methodologies and enhance the (NeRSAP), the OECD Working Party on Risk
capacity of Member States and Management and related workshop on safer
companies to carry out analysis of alternatives, as well as various environmental
alternatives and socio-economic and human health economists networks. In
analysis with view of finding viable support to substitution, we focused on
alternatives. maintaining ECHA's dedicated webpages,
including its online training module, and in
following the developments of the
Commission’s substitution-related studies.
Indicators Estimate Actual
Number of RAC and SEAC opinions adopted on applications for 40 55
authorisation (number of uses)
Restrictions12
Objective 1: Commission supported in the implementation of the Restrictions Roadmap.
Main Outputs Execution Status
Annex XV dossiers proposing The requested investigation report on No
restrictions and/or investigations Aromatic Brominated Flame-retardants,
developed for 2-3 substances or covering 60 substances, was finalised and
groups of substances from the published. The restriction dossier on
restriction roadmap at the request of chromium (VI) substances, originally due to
the Commission. be completed in 2024, was delayed as the
Commission requested ECHA to expand the
scope and therefore the timeline for the
submission of this dossier was postponed to
April 2025.
Screening reports for 2-3 We delivered 4 screening reports, analysing Yes
substances under Article 69(2) whether there is a need for restricting the use
prepared. in articles for substances subject to
authorisation (Art.69.2).
Indicators Estimate Actual
Restriction proposals or investigation/screening reports developed 5 5
12
Title VIII of Regulation (EC) No 1907/2006
29
Annual Report 2024
Objective 2: Opinions of the Committees for Risk Assessment (RAC) and Socio-Economic
Analysis (SEAC) are timely, robust and fit-for-purpose.
Main Outputs Execution Status
Robust opinions on restrictions The opinion of the scientific committees (RAC Yes
delivered to the Commission. and SEAC) on the restriction dossier for
creosote was delivered to the European
Commission.
The committees made progress in evaluating
the PFAS restriction dossier that was
submitted by five countries in 2023. They
arrived at provisional conclusions on hazards
and on eight sectors and uses of PFAS and will
continue the evaluation in 2025 based on the
work of the dossier submitters.
Methodologies related to socio- We maintained our involvement in Yes
economic analysis developed and methodological development-related
explained to create a fit-for-purpose activities, including the valuation of five
toolbox, including the valuation of human health-related endpoints
various health and environmental (hypothyroidism, hypertension, non-fatal
endpoints in collaboration with the cancer, skin sensitisation, and miscarriage)
OECD and in line with the under the OECD SWACHE project. We also
Commission’s Better Regulation actively contributed to the first steps of a
guidelines. similar project for environmental endpoints
(OECD SACRE).
Indicators Estimate Actual
Number of RAC and SEAC opinions on restriction proposals 1 1
Objective 3: Commission supported in their decision-making tasks.
Main Outputs Execution Status
Case-specific support provided to At the request of the Commission, we Yes
Commission in the decision-making provided support in the decision-making
phase of the restriction process. phase related to four restriction proposals:
PFAS in fire-fighting foams, PAH in clay
targets, skin sensitisers and lead in shooting
and fishing.
General and specific guidance to aid The guideline on the Formaldehyde restriction No
the implementation of Annex XVII was developed in 2024 as mandated by the
restriction entries (e.g., Commission. Incorporation of the
Formaldehyde) delivered to the Commission's suggestions was ongoing at
Commission. year end. The guideline is expected to be
submitted to the Commission in the first
quarter of 2025 and subsequently published
on the ECHA website.
General and specific technical We supported the Commission in developing Yes
support to aid the implementation of guidance on the microplastics restriction and
Annex XVII restriction entries (e.g., in developing a microplastics reporting system
microplastics), delivered to the as part of the implementation of that
30
Annual Report 2024
Commission. restriction. A proposal for implementing these
requirements was agreed with the
Commission and will be made available in
2025.
Indicators Estimate Actual
Number of cases in decision making where support is provided 4 4
Number of reports 1 0
Number of Annex XVII entries where implementation support is 1 1
provided
Classification and labelling 13
Objective 1: Opinions of the Committee for Risk Assessment (RAC) are timely and fit-for purpose.
Main Outputs Execution Status
CLH dossiers, including individual 60 dossiers with proposals for harmonised Yes
and groups of industrial chemicals classification were received and 56 opinions
from the outcome of identification on harmonised classification by RAC were
and prioritisation processed in line adopted.
with legal requirements.
All harmonised PPP and biocides All harmonised PPP and biocides dossiers were Yes
dossiers processed in line with legal processed within the legal deadlines.
requirements.
Joint Commission, EFSA and ECHA Alignment on this objective was not prioritised No
efforts to encourage the timely for completion.
submission of PPP and biocide
dossiers completed.
Indicators Estimate Actual
Proposals for harmonised classification and labelling 50 60
Number of RAC opinions on proposals for harmonised classification 50 56
and labelling
Objective 2: Member States, Commission services and duty holders supported to fulfil their legal
obligations.
Main Outputs Execution Status
Guidance made available and We continued supporting the European Yes
updated as necessary. Commission in the review of the CLP
Regulation, which was published in late 2024.
Guidance and support on CLP were updated to
13
Regulation (EC) 1272/2008
31
Annual Report 2024
include the new hazard classes. This was a
significant collaborative achievement
delivered under tight deadlines by experts
from ECHA, EU Member States, EU level non-
governmental organisations and others, with
input from an extensive stakeholder
consultation.
Decisions made on requests to use We received 20 requests to use an alternative Yes
an alternative chemical name in line chemical name, a lower number compared to
with legal requirements. previous years. All requests were processed in
accordance with legal requirements.
Scientific and technical support We provided regular support to the Yes
provided to the Commission in the Commission in the context of the United
context of the further development Nations’ Globally Harmonised System of
of the United Nations Globally classification and labelling of chemicals (UN
Harmonised System of classification GHS).
and labelling of chemicals (UNGHS),
and in particular including advice
on:
• the new hazard classes and
criteria for endocrine
disruptors; PBT, vPvB, PMT,
vPvM; neurotoxicity and
immunotoxicity; terrestrial
toxicity in GHS.
• the implementation of revisions
8, 9 and 10 of UNGHS.
• the work of selected GHS
working groups, notably the
working group on the use of
non-animal testing methods for
classification.
Scientific and technical support We provided support to the Commission in the Yes
provided to the Commission in the implementation of the revisions of the CLP
implementation of the revisions of regulation and the UNEP GHS project in
the CLP regulation and the UNEP African countries.
GHS project in African countries.
Indicators Estimate Actual
Decisions made on requests to use an alternative chemical name (Art 40 20
24 CLP)
Objective 3: Up-to-date information on the classifications for chemicals, both harmonised and
non-harmonised, publicly available.
Main Outputs Execution Status
First version of the new C&L The delays in setting up the new public cloud No
inventory launched as part of IT environments and infrastructure resulted in
ECHA’s new public data availability the launch of the C&L inventory being
32
Annual Report 2024
system. The new version will take postponed from November 2024 to Q2 2025.
into account the changes in the
Tools and support materials were updated to
revised CLP regulation.
take account of the review of the CLP
Regulation.
Indicators
N/A
Objective 4: Structured, high quality and consistent information for the EU poison centre scheme
is timely available across Europe.
Main Outputs Execution Status
Notification portal and system-to- We maintained and successfully adapted the Yes
system submission channel notification portal and system-to-system
maintained and adapted to meet the submission channel to meet the requirements
requirements stemming from the stemming from the revision of the CLP
revision of the CLP Regulation and Regulation and changes with IUCLID.
changes with IUCLID.
Actions to address issues with We began addressing the misuse of UFIs and No
misuse of UFIs identified and finalised an information package aimed at
delivered in conjunction with MS helping companies avoid misuse which will be
Competent and Enforcement published in 2025. Additional input from
Authorities. Member States and Appointed Bodies on UFI
misuse was sought for further investigation.
PCN activities promoted and support We provided ongoing support to companies Yes
provided to companies and Member and Member States following the entry into
States following the entry into force force of the notification obligation for mixtures
of the notification obligation for with industrial uses. Appointed Bodies and
mixtures with industrial uses of 1 Poison Centres regularly used the PCN central
January 2024 and in view of the end database to perform their duties under Article
of the transition period on 1 January 45, Annex VIII. The number of poison centre
2025, as well as with regard to notifications viewed by national authorities in
adaptations stemming from the the PCN central database exceeded our
revision of the CLP Regulation. estimate, with 22,775 views compared to the
anticipated 15,000.
Indicators Estimate Actual
Poison centre notifications received and made available to Appointed 2 to 3 3 148 898
Bodies and Poison Centres million
Poison centre notifications viewed by national authorities in the PCN 15 000 22 775
central database
33
Annual Report 2024
Objective 5: ECHA advice, processes and tools, resulting from the revision of CLP, updated and
communicated.
Main Outputs Execution Status
Guidance and support on CLP Guidance and support on CLP were updated to Yes
updated to include the new hazard include the new hazard classes and published
classes. by year end.
Guidance to support CLH for groups We continued assisting Member States in Yes
of substances. developing dossiers for Harmonised
Classification for 10 groups of substances that
originated from the chemical universe
screening. This included ad-hoc support
requested by three Member States and
preparing a shortlist of seven group CLH
candidates presented to the RiME+ meeting.
Support mechanisms for Member We provided advice to various relevant fora on Yes
States in the preparation of CLH the role of the Expert Groups and how to
dossiers including for the new receive support.
hazard classes established,
including the clarification how the
PBT and ED expert groups can
support the work.
Data submission formats and tools We successfully adapted data submission Yes
adapted to the requirements of the formats and tools to the requirements of the
revised CLP regulation. revised CLP regulation.
Indicators
N/A
Data management and dissemination
Objective 1: Regulatory processes performed by relevant actors based on robust data and IT
systems.
Main Outputs Execution Status
Data governance to support We initiated the implementation of our new Yes
regulatory data consistency, data management approach and established a
coherence, transparency and Data Governance Office responsible for
reporting across regulations managing our regulatory data. This work will
consolidated. continue and will be further shaped to support
regulatory data consistency, coherence and
transparency.
Interact Portal (including ACT) We maintained and further developed the Yes
maintained with due consideration Interact Portal, including ACT, which
of process and users’ requirements. introduced enhanced functionalities were
introduced such as a tracking list for ACT and
email notifications.
Case management capabilities First versions of the core case management Yes
further developed to onboard new modules (task, process, case, and portal)
34
Annual Report 2024
tasks and increase efficiency of were set up. These modules will be used in the
existing regulatory processes. delivery of the IT solution to support the
Drinking Water Directive process as part of
our IT Transformation. These and then they
will be further applied in other regulatory
processes in the future.
Chemical identifiers data We initiated implementation of a new Yes
management reviewed to increase Chemicals Identifiers Management System to
its efficiency and effectiveness. manage the inherent differences between
regulatory contexts and prepare the Agency
to onboard new tasks.
Tools to search, extract and analyse We maintained and made accessible to Yes
data maintained and accessible to authorities and industry tools to search,
authorities and industry. extract, and analyse data.
Data analysis services completed Our data services supported the Commission Yes
upon request from EU institutions or and Member States on scientific data analysis.
Member States. This included assisting the Commission with
the revision of the EU UWWT (Urban
Wastewater Treatment Directive
91/271/EEC); providing information on
substances in electronic devices to support
Member States regulatory work; supporting
the preparation of ECHA investigation report
on aromatic brominated flame retardants,
which will aid the Commission in deciding on
the scope and need for further regulatory
action.
Indicators Estimate Actual
Number of data provision and analysis requests 70 61
Objective 2: Transparent and public access to data submitted under different regulations as well
as progress on regulatory activities made available.
Main Outputs Execution Status
First version of ECHA’s new public The first version of the new system for making Yes
data availability system launched, information on chemicals publicly available,
including hazard, use and ECHA CHEM, went live in Q1 2024, covering
classification data from registration information from registration dossiers.
dossiers.
New solution for dissemination of Further extension of the scope of ECHA CHEM No
regulatory data integrated into had to be postponed to 2025, due to delays
ECHA’s new data availability system. encountered with the set-up of the new cloud-
based IT infrastructure and the need to
address an unforeseen IT incident affecting
the publication of information from
registration dossiers.
OECD Global Portal to Information The OECD eChemPortal was maintained as No
on Chemical Substances planned, but the data refresh to ECHA’s
(eChemPortal) maintained and dissemination website was not completed due
35
Annual Report 2024
synchronised with ECHA’s to the transition to ECHA CHEM, the new ECHA
dissemination website. dissemination website. The refresh will be
aligned with the new system going forward.
Indicators
N/A
Promotion of alternatives to animal testing
Objective 1: Industry generates hazard data using non-animal testing methods and new
approaches.
Main Outputs Execution Status
Development of the QSAR toolbox to Two versions of the QSAR Toolbox were Yes
integrate new information (for released in 2024. Key achievements include
example, metabolites, biocides or the full implementation of Meta Map,
data from pharmaceuticals) and compatibility with the latest IUCLID version,
models further developed. and the integration of new databases.
Data available for download (REACH This output was not achieved due to the No
studies results and pharmaceutical change in technology for the dissemination of
industry data contribution) registration dossiers, transitioning to the new
expanded to be used for NAMs ECHA CHEM platform. As a result, no updates
development and/or avoiding were made in 2024.
unnecessary animal testing.
Predictive models to support Due to budget constraints, further No
prioritisation and scientific decision deployment of modules could not be achieved.
making further implemented.
Application of the OECD QSAR We provided all necessary support for the Yes
Assessment Framework supported. application of the OECD QSAR Assessment
Framework.
Indicators
N/A
Objective 2: ECHA information and advice on alternatives to animal testing provided to policy
makers and stakeholders.
Main Outputs Execution Status
OECD activities related to further We finalised drafting the OECD Guidance for Yes
development of alternatives and Omics Sampling.
integration of regulatory relevant
alternatives in test guidelines
supported.
Development of high throughput We also rolled out our own projects to reduce Yes
NAMs in cooperation with ECHA’s reliance on animal testing while maintaining
36
Annual Report 2024
international partners progressed. protection of human health and environment.
For example, we contracted a collaborative
consortium of researchers to conduct scientific
studies on the reliability and relevance of New
Approach Methodologies (NAMs) as
alternatives to animal testing and to promote
the use of such methods in the future. The
contract will run for six years and has a total
value of EUR 4.2 million in funding. These
projects will investigate the application of
omics in regulatory contexts to enhance read-
across and grouping methodologies; explore
potential alternatives to current aquatic
toxicity testing involving the use of fish; and
examine the use of in vitro toxicokinetics to
support hazard assessment.
We also supported a case study under the Risk
Hunter research consortia. The case study
aimed at classifying substances as toxic
(STOT RE classification) or non-toxic (NOAEL
≥ 1000 mg/kg bw) using bio-spider
sequencing.
International collaboration towards We invested in international activities, Yes
the identification and acceptance of particularly Accelerating the Pace of Chemical
alternatives in regulatory Risk Assessment (APCRA), Partnership for the
frameworks (e.g., with US and Assessment of Risks from Chemicals (PARC)
Canada within the APCRA initiative and Organisation for Economic Co-operation
(Accelerating the Pace of Chemical and Development (OECD) activities and
Risk Assessment)) maintained. finalised a number of case studies with them.
For example, a case study for systemic
toxicity, characterisation of the uncertainty for
high throughput toxicokinetic, and analysis of
the toxicological concordance between animal
and human data.
We worked closely with the European
Commission to support development of a
roadmap to phase out animal testing.
Indicators
N/A
37
Annual Report 2024
Biocides14
Objective 1: Active substance and Union authorisation opinions are timely and of high quality.
Main Outputs Execution Status
Opinions on the approval and We finalised 15 opinions on active substances Yes
renewals of active substances and and one opinion on a review of the approval
on Union authorisation of biocidal of an active substance. The overall progress
products prepared. of the active substances Review Programme is
now at 50%. We delivered 17 opinions on
Union authorisations as well as 8 opinions
following Art. 75(1)(g) requests from the
Commission.
Opinions on Union authorisation of We delivered 15 opinions on Union Yes
same biocidal products and on authorisations of same biocidal products, as
administrative changes of the Union well as 20 opinions on administrative changes
authorisations prepared. of Union authorisations.
Opinions on minor changes and We delivered four opinions on minor changes Yes
major changes of the Union of Union Authorisations, and one opinion on a
authorisations prepared. major change of a Union Authorisation.
Additionally, we finalised eight opinions on
classification of changes of biocidal products.
Cooperation with EFSA further We continued to collaborate with other Yes
advanced to implement the basis agencies. With EFSA we developed consistent
and mechanisms for alignment of guidance documents, such as on risk
evaluation of common substances assessment for pollinators.
(one substance, one assessment).
We also cooperated with EFSA, EMA and
ECDC, on a report to address anti-fungal
resistance (Aspergillus) that was endorsed by
BPC.
List of frequently used sentences in The list of frequently used sentences in the Yes
the SPCs updated and translated in SPCs is updated every two years. It was
all the EU official languages. updated and translated into all EU official
languages in 2023. It will be updated again in
2025.
Assessments of applications for Decisions on technical equivalence (32) and Yes
technical equivalence, inclusion in inclusion in Art. 95 list remained a sustained
the Article 95 BPR list and output, as in previous years, contributing to
classification for of changes the total amount of work involved in
performed. implementing the Biocidal Products
Regulation.
Indicators Estimate Actual
Number of opinions on active substances [approval & renewal] 15 15
Number of opinions on Union authorisation of biocidal products 20 17
Number of opinions on Union authorisation and related processes: 35 40
14
Regulation (EU) No 528/2012
38
Annual Report 2024
same biocidal products, administrative, minor and major changes.
Number of technical equivalence application assessments 30 32
Objective 2: Member States and Commission supported to facilitate biocides processes and
accelerate the Review Programme.
Main Outputs Execution Status
Regulatory, procedural and We provided regulatory, procedural and Yes
technical support provided to the technical support to MCSAs. We also took
competent authorities of the additional steps to improve the
Member States (MSCAs) in the implementation of the Biocidal Products
evaluation and BPC opinion forming Regulation, for instance, by improving the
on the approval of active part of BPC opinions on analysis of
substances, including also on alternatives and exclusion derogation criteria,
measures defined in connection with improving the consultation practice for
the prolongation of the Review analysis of alternatives and inclusion of
Programme, and on Union derogation criteria.
authorisation of biocidal products.
We provided secretariat support to the
Coordination Group, assisting Member States
in resolving disagreements during mutual
recognition of biocidal products authorisations
and in reaching agreements on horizontal
topics to prevent future disagreements.
We further improved working procedures,
such as the active substance renewal
procedures, as well as on the renewal of Union
authorisations (working procedure, SPC
linguistic review, criteria for full evaluation,
guidelines for submission of applications). A
recommended approach to address in situ
active substances was endorsed by the
Commission and Member States.
Contribution made to MSCAs We organised information sessions and a Yes
capacity building by providing campaign for direct support to Member States
training and scientific-technical in requesting endocrine disruptors (ED) data
advice, including also on endocrine- for all pending cases by June 2024. This is a
disrupting substances and analysis prerequisite to obtain all necessary ED data by
of alternatives. the end of 2026 and conclude the evaluation
accordingly.
In the annual survey, the EU biocides
authorities expressed a very high level of
satisfaction with the work of ECHA, increasing
from 84% to 95%.
BPC opinions requested by the We delivered 10 opinions following requests Yes
Commission pursuant to Articles 38, from the Commission according to Articles 15,
15(2) and 75(1)(g) of the BPR 38 and 75(1)(g).
prepared.
Guidance developed and maintained Several guidance documents were developed Yes
aiming for alignment as far as EU or updated including the guidance on risk
Regulations allow. assessment for pollinators; practical guide for
letters of access; update of efficacy guidance;
39
Annual Report 2024
guidance to reduce exposure of cats to
pyrethroids; endorsement of approach to
address in situ substances.
Support to the development of an We delivered a solution to easily identify and Yes
easily accessible and structured access relevant documents.
overview of ECHA guidance
documents and relevant policy
documents provided.
Indicators Estimate Actual
Satisfaction of authority actors Positive trend 95 %
Number of opinions on Article 15, Article 38 and Article 75(1)(g) 10 10
requests
Objective 3: Biocides IT tools integrated with other ECHA regulatory IT systems.
Main Outputs Execution Status
Specialised Biocides IT tools We adapted IUCLID to integrate the Yes
integrated with ECHA IT systems. preparation of the summaries of biocidal
product characteristics (SPCs). The previous
‘SPC Editor’ was discontinued.
Development continued for the R4BP 3 was maintained and improved through Yes
Register for Biocidal Products (R4BP two major releases. Progress was made in
3) and other IT support tools (e.g., aligning it further with ECHA target modular
Chesar platform). architecture. We continued collecting user
information and exchanging through the BPR
IT user group.
Transition of evaluation dossiers We made good progress in developing the first Yes
into IUCLID format for active set of IUCLID quality rules for applications of
substances and Union authorisation active substance approval.
cases initiated.
Indicators
N/A
Contribution to EU Environmental policy
Objective 1: international trade of chemicals listed under the Rotterdam Convention and the PIC
regulation facilitated and managed.
Main Outputs Execution Status
Received export notifications We received 10,448 export notifications and Yes
processed. successfully processed all of them.
Support provided to EU MS DNAs We provided support to EU MS DNAs and the Yes
and the Commission, including the Commission, including the management of
management of explicit consent explicit consent requests, to allow companies
40
Annual Report 2024
requests, to allow companies to to export these chemicals in accordance with
export these chemicals in the EU’s international commitments.
accordance with the EU’s
international commitments.
Support to companies (via the Support was provided as requested. Yes
helpdesk) and non-EU Authorities
provided.
Fifth biannual report on the The report was published in October 2024. Yes
exchange of information under the
PIC Regulation (Art. 20) published.
Annual report on PIC exports and The annual report published, showed that EU Yes
imports (Art. 10) published. chemical exports under PIC remained at
similar levels to previous years.
Support provided to the Commission We provided support to the Commission with Yes
with the EU contribution to the the EU contribution to the Rotterdam
Rotterdam Convention Convention Implementation.
implementation.
Support provided to the Commission We continued providing support to the Yes
in the continuous improvement of Commission on improving the efficient
the efficient implementation of the implementation of the PIC Regulation,
PIC Regulation, including any follow- including follow-ups to ECHA’s third report on
ups to ECHA’s third “report on the its implementation. We also contributed input
implementation of the PIC to the Commission for the evaluation and
Regulation”, and providing input to follow-up of the regulation.
the Commission in the evaluation
and follow-up of the PIC Regulation.
Indicators Estimate Actual
Export notifications processed 11 000 10 448
Share of notifications validated by ECHA 90 % 94 %
Support provided to PIC duty holders (importers and exporters) 250 253
Objective 2: European Commission supported in the implementation of the Stockholm
Convention and the POP Regulation.
Main outputs Execution Status
Scientific dossiers drafted for a new We updated the draft scientific dossier (Annex Yes
EU proposal to list a potential POP D proposal) for Octamethylcyclotetrasiloxane
substance under the Stockholm (D4), Decamethylcyclopentasiloxane (D5) and
Convention on Persistent Organic Dodecamethylcyclohexasiloxane (D6) based
Pollutants. on new available information. At the European
Commission’s request, we conducted a
screening exercise to identify substances that
could meet the POP criteria, with the aim of
identifying a new candidate for an EU
proposal. We presented the screening results
at the POP Competent Authorities Expert
Group meeting in November 2024.
41
Annual Report 2024
Technical and scientific support Under the EU Persistent Organic Pollutants Yes
provided as required to the (POPs) Regulation, we provided technical and
Commission for the listing process. scientific support to the Commission for
discussions at the 20th meeting of the POPs
Review Committee (POPRC-20). We actively
participated in discussions related to the
addendum for the risk management
evaluations of Medium-chain Chlorinated
Paraffins (MCCPs), chlorpyrifos and long-chain
PFCAs. All substances (MCCPs, chlorpyrifos
and long-chain PFCAs) were recommended for
listing under Annex A of the Stockholm
Convention, with specific exemptions. The
Committee also agreed that polybrominated
dibenzo-p-dioxins and dibenzofurans and
mixed polybrominated/chlorinated dibenzo-p-
dioxins and dibenzofurans met the screening
criteria in Annex D to the Convention.
The reporting system for the The Union Overview report was updated in Yes
implementation of the POP February 2024.
regulation maintained and the Union
Overview report based on the
Member States reports updated.
These outputs will be delivered in
line with resource constraints.
Indicators Estimate Actual
Number of scientific dossiers drafted for the identification of new 1 1
substances as Persistent Organic Pollutants
Support provided to various stakeholders 50 70
Scientific and technical support provided to the Commission, EU and 10 35
non-EU CAs
Objective 3: Substances of very high Concern In Products (SCIP) database maintained.
Main outputs Execution Status
Notification portal and the public We successfully maintained the Notification Yes
SCIP database maintained. portal and the public SCIP database, ensuring
continuous operation and accessibility
throughout the year.
Support provided to EU suppliers of We provided ongoing support to EU suppliers Yes
articles to submit the required of articles, assisting them in submitting the
information to ECHA. required information to ECHA in a timely and
efficient manner.
Indicators Estimate Actual
Successful SCIP notifications received (incl. updates) 8-12 million 12 257 502
42
Annual Report 2024
Objective 4: Implementation plan for ECHA’s role under of Article 11 of the revised Drinking
Water Directive in place.
Main outputs Execution Status
Technical and scientific support to We continued our preparatory work to ensure Yes
the Commission provided on readiness of the entry into operation of the
drafting and adopting the directive’s provisions relevant for ECHA’s role.
Implementing and Delegated acts. We prepared scientific guidance for the
potential applicants and held a webinar on the
new obligations under the directive.
Internal operational procedures and We continued to work on setting up the No
working instructions for handling the process and the IT tools needed to ensure
applications to be submitted from smooth and timely handling of notifications
2025 onwards established. and applications as well as delivery of the
opinions under Art. 11 of the directive. The
Procedures for opinion forming by No
implementation of the provisions for
RAC and the Working Group
notification and application systems have
developed and implemented.
been delayed by one year by the legislator.
IT tools for the reception, processing No
Accordingly, the implementation of the related
and dissemination of applications,
tools and procedures have been slightly
including the adaptation of IUCLID
deprioritised during 2024. This work will
to the specific needs of the DWD
continue in 2025.
process, developed and
implemented.
Objective 5: an accessible and transparent evidence base to support the monitoring, measuring
and reporting on chemicals.
Main outputs Execution Status
Relevant indicators developed that ECHA indicators and signals were developed Yes
are based on accessible and in time for publication in the dashboard
transparent evidence and enable the
monitoring, measuring and
reporting on chemicals.
Public version of the indicator Under the 8th Environmental Action Yes
framework prepared and published Programme (EAP), we developed the indicator
jointly with EEA and the framework jointly between Commission,
Commission. ECHA and EEA. The final framework was
published on the EEA website.
Joint synthesis report, offering The joint synthesis report was prepared and Yes
policy-relevant messaging on the published on the EEA website together with
trends observed in the chemicals the framework in April 2024.
indicators prepared.
Objective 6: implementation of the Batteries Regulation.
Main outputs Execution Status
First part of the study completed, As 2024 was the first year of implementation No
detailing the identification and of the ECHA tasks under the Batteries
engagement with all main batteries’ Regulation, the first phase of the scoping
stakeholders, including waste study was only launched and is expected to be
43
Annual Report 2024
batteries, the investigation on the concluded in Q2 2025.
possibility to amend current
In preparation for this new task, the multi-
restrictions (under ELV Directive) for
annual work plan for implementing the
Mercury, Cadmium and Lead in
batteries regulation at ECHA (implementation
batteries in Annex I of the Batteries
plan) was approved.
regulation and the foundation for
the second part of the scoping The first phase of the scoping study was
study. launched in 2024 and is expected to be
concluded in Q2 2025.
Workshop with all relevant Two workshops were organised with relevant Yes
stakeholders organised and follow- stakeholders in April and October 2024. The
up actions implemented as follow-up actions were fed into the scoping
necessary. study development and onboarding of
batteries restrictions work at ECHA.
Objective 7: preparation for the implementation of the Water Framework, Groundwater and
Environmental Quality Standards (EQS) Directives.
Main outputs Execution Status
Technical and scientific support In addition to support provided to the Yes
provided to the Commission in Commission on request, we set up
assessing changes proposed by cooperation with Commission, EEA and JRC to
Council and EP and any new drafts ensure smooth hand over of tasks, as well as
prepared. following as observers some of the working
group meetings of the Commission with
relevant stakeholders.
Setup of internal operational The legislative process was delayed in 2024 No
procedures and working instructions and therefore the readiness for entry into
for implementation of the tasks operation on ECHA side was delayed
established. accordingly. The focus in 2024 was on
developing further understanding of the tasks,
to identify the necessary expertise needed
within the secretariat and in the RAC/SEAC
committees.
Objective 8: further development of Best Available Techniques Reference (BREF) documents
under the Industrial Emissions Directive supported.
Main outputs Execution Status
Expert and relevant input on ECHA received a formal role in 2024 under the Yes
chemicals provided to the JRC and Industrial Emissions Directive. We supported
IED Forum provided. the initiation of a new Best Available
Techniques (BAT) reference documents
(BREF) on ore mining, by providing
information from ECHA’s chemical databases
to assist in the identification of relevant input
chemicals and potential Key Environmental
Issues.
Assistance given to the BREF We supported EU-BRITE with ad hoc Yes
development and chemical risks are consultations e.g., on ongoing BREFs,
inclusion of chemical management systems in
44
Annual Report 2024
addressed as appropriate. BAT-C (Best Available Technique Conclusion)
documents and feedback on potential
Guidance development.
Workplan for the further This output was deprioritised in 2024 to No
development of the Chemical enable ECHA to shift focus to supporting the
Management Systems methodology BREF process.
(to prioritise chemicals for
prevention/control of emissions
from industrial installations)
developed and agreed.
Tasks under grant, cooperation and service-level
agreements
Objective 1: EUON database on nanomaterials on the EU market available and updated.
Main Outputs Execution Status
Specific data gaps in the public Two studies were completed, and two new Yes
knowledge about nanomaterials via ones were launched, in accordance with the
the commissioning of external EUON work plan.
studies addressed.
Database updated as necessary with The EUON was updated with new content such Yes
new or changing regulatory or as study reports and Nanopinions.
scientific information.
An evaluation of the functioning of the EUON
was also performed providing insights and
recommendations on the further development
of EUON including its integration in the future
Common data platform of chemicals as
proposed by the Commission.
EUON promoted via different Social media campaigns were delivered and Yes
channels to increase its outreach to found to be an effective tool to direct users to
a wide variety of audiences. EUON.
Indicators Estimate Actual
All traffic to EUON websites 130 000 182 285
Objective 2: EUCLEF database on EU chemicals legislation available and updated.
Main Outputs Execution Status
EUCLEF maintained and updated. Information on regulatory obligations on Yes
chemicals was maintained and regulatory
changes reflected.
EUCLEF promoted wider to increase Information on regulatory obligations on Yes
the utility of the service for the chemicals was promoted especially towards
target audience, with a particular SMEs as per the agreement with Commission
focus on SMEs.
45
Annual Report 2024
Advice provided via the EUCLEF The outsourced EUCLEF helpdesk continued to Yes
helpdesk. provide timely support to customers.
Indicators Estimate Actual
All traffic to EUCLEF pages 15 400 000 439 924
Objective 3: Opinions of the Risk Assessment Committee (RAC) on OELs delivered to the
Commission.
Main Outputs Execution Status
SLA requests processed to agreed Five new requests for setting occupational Yes
timelines. exposure limits were received under the 2024
contribution agreement with the Commission:
• N-(Hydroxymethyl)acrylamide (NMA)
• Ethylene dibromide or 1,2-
Dibromoethane (EDB)
• Anthraquinone
• 1,3-Propanesultone
• Oximes (butanone oxime and acetone
oxime)
The RAC opinions for these substances must
be adopted by 30 April 2026.
Five RAC opinions completed and The RAC opinions on scientific evaluations of No
delivered to the Commission. occupational exposure limits (OELs) for four of
the five substances agreed for 2023 were
adopted. The five substances included:
• Boron and its compounds
• 1,3-Butadiene
• 1,2-Dihydroxybenzene (Pyrocatechol)
• Silicon carbide fibres
Exceptionally discussions on the fifth
substance, Bisphenol A (BPA) (and other
Bisphenols), were not completed with the RAC
opinion scheduled to be adopted in 2025.
Indicators Estimate Actual
Number of OEL requests received under SLA 5 5
Number of RAC opinions on OELs completed 5 4
Number of scoping documents 1 0
15
Traffic aggregated for all the EUCLEF pages, including EUCLEF main landing page, Information for Chemicals
(EUCLEF subset) and EUCLEF Legislation Lists for substances.
46
Annual Report 2024
Objective 4: IPA grant implemented fully in support of EU candidate and pre-candidate countries
on chemicals management.
Main Outputs Execution Status
Support actions as agreed in the IPA We delivered support to pre-candidate Yes
grant agreement for 2023-June countries with the implementation of the
2026 implemented. chemicals acquis. IPA countries attended
several relevant meetings and trainings
including capacity building on enforcement
and communication.
Indicators
N/A
Objective 5: IUCLID platform cooperation on Plant Protection Products (PPP) between EFSA and
ECHA continued.
Main Outputs Execution Status
Submitted dossiers processed and ECHA continued to support EFSA Industry Yes
made available to EFSA. access to ECHA Cloud Services and
consolidated PPP submission processes.
Applicability of IUCLID to other food ECHA and EFSA discussed and agreed on the Yes
regulated products (e.g., Food IUCLID requirements for Food Contact
Contact Materials and synergies with Material (IUCLID format). The implementation
Drinking Water Directive and Feed of the agreed requirements in IUCLID will
additives) reviewed and assessed. start in 2025.
Support provided to EFSA with the ECHA delivered to EFSA several updates of the Yes
use of IUCLID data tools for the IUCLID data tools, and supported EFSA
extraction, search and upload of contractor with curating and populating data
data. (e.g. on food toxicity) in EFSA IUCLID
database.
Indicators
N/A
Objective 6: Input provided to research activities in support of current and future regulatory
challenges
Main Outputs Execution Status
Framework developed with clear As a co-leader of Task 2.1 ‘Priority setting’ Yes
decision criteria to enable under PARC, ECHA’s experts reviewed 46
transparent decision making for the projects, mainly related to hazard, exposure
prioritisation of activities within and risk assessment methodologies.
PARC.
Development of annual work plans We actively participated in PARC projects Yes
supported and steered to ensure addressing data gaps, for example, on
47
Annual Report 2024
identified EU priorities and immunotoxicity and development of
knowledge gaps in the area of innovative methods on different hazard
chemical risk assessment endpoints (e.g. developmental neurotoxicity).
appropriately considered.
We have further updated the regulatory
research needs in our document called ‘Key
Areas of Regulatory Challenge’ (KARC). The
second version of this KARC report was
launched during a joint webinar together with
the EEA and EFSA (European Food Safety
Authority) in June. These updated research
needs serve as an important source of
inspiration feeding into the key priorities for
future research projects for the last three
years of PARC.
We presented these research needs in various
scientific fora (e.g., ECETOC- LRI Scoping
meeting, Workshop Future chemical Risk
Assessment and Management at University of
Gothenburg, Helsinki Chemical Forum, etc.).
Advice and steer provided to the We have submitted together with the Yes
development and implementation of European Environmental Agency (EEA) an
a rapid response mechanism to urgent request to generate exposure data on
allow national and European policy a phthalate of concern via the Rapid Response
makers to submit requests for Mechanism.
specific information to the PARC
Consortium outside of the formal
timeframes.
Indicators
N/A
Governance and Enablers
Objective 1: A level playing field for economic operators through harmonised enforcement.
Main Outputs Execution Status
Reports on five Forum-coordinated All anticipated enforcement projects went Yes
REACH and BPR enforcement through the different phases without delays.
projects prepared, published and Reports and findings were published and
communicated. Reports include communicated.
REACH and POP Restrictions (REF-
10), REACH safety data sheets
(REF-11), control of REACH for
imports (REF-12), online sales (REF-
13), BPR approved substances in
biocidal products containing non-
approved/approved active
substances (BEF-2) and control of
SPC and SDS for biocides (BEF-3).
48
Annual Report 2024
Subject matter of next REACH The classification and labelling of mixtures in Yes
project (REF-14) agreed and steps products was agreed as the next Forum
taken to implement actions. project (REF-14) and will commence in 2027.
Best practice enhanced by Updates to Manuals of Conclusions were made Yes
maintaining the Forum and BPRS on a regular basis. Pilot projects (PFCAs in
Manuals of Conclusions on practical cosmetics, PCN notifications, bridging
enforcement issues and running principles) progressed according to plans.
Forum pilot projects on PFCA
(Perfluoroalkyl carboxylic acids) and
related substances and poison
centre notifications.
Advice on enforceability on all Advice was delivered. Yes
submitted proposals for restrictions
delivered and published.
Process revised for delivering the Process was revised, reviewed and accepted Yes
Forum advice. by the Forum.
New version of the compendium of A new draft version was made available. Yes
analytical methods prepared.
Four trainings for national trainers Trainings took place, with some 730 Yes
and inspectors developed and participants, which was much higher than
delivered. estimated.
Forum’s input provided on the The Commission’s work on revising the REACH No
Commission’s views on enforcement Regulation is ongoing. ECHA anticipates a
related topics under the CSS/REACH proposal for a revised Regulation in 2025 and
revision and the impact of any will work closely with the Commission to
proposed legislative changes on the provide input and support the development
operation of the Forum reviewed. and implementation of the proposal.
Indicators Estimate Actual
Number of enforcement trainers trained by the Forum 200 730
Number of enforcement projects ongoing 5 9
Objective 2: Board of Appeal 16 decisions are adopted without undue delay and are of high
quality.
Main Outputs Execution Status
Appeals brought against decisions In 2024, eight appeal cases were received, Yes
of the Agency, according to and 14 appeal cases were closed.
procedural requirements,
processed and decided.
Communication to parties and the Section on the Board of Appeal on the ECHA Yes
public about appeal decisions website was revised to make it easier for
completed. stakeholders to find decisions and other
information on appeals.
16
Art. 90 of Regulation (EC) No 1907/2006 and Art. 77 of Regulation (EU) No 528/2012
49
Annual Report 2024
Support provided to the Secretariat Staff of the Registry supported the Yes
in defence of Board of Appeal Secretariat in representing ECHA in two
decisions when challenged before cases before the General Court.
the EU Courts.
Contributions provided to ECHA’s The Registry and the Board of Appeal Yes
input for the review of the REACH provided input to the secretariat, as
Regulation. required, with regard to processes within the
competence of the Board.
Indicators Estimate Actual
Appeals submitted REACH 12 8
Appeals submitted BPR 2 0
Appeals concluded REACH 12 11
Appeals concluded BPR 2 2
Objective 3: ECHA's Governance aligns with strategy and adapts to the changing organisational
and institutional landscape.
Main Outputs Execution Status
Four Management Board meetings Five Management Board meetings were Yes
with related subgroups and an organised, including one extraordinary
external assessment of the Board meeting. The Management Board decided to
organised. conduct a self-evaluation 17 without external
support, which was run between April and
August 2024.
Due to the extraordinary Board meeting
scheduled, and in agreement with the Chair,
the timelines for providing documentation
were shortened. This is reflected in the fact
that the relevant indicator achievement rate
is 83% instead of 95%.
All statutory documents required by All statutory reports were approved by the Yes
legislation in the area of planning Management Board in line with regulatory
and reporting are prepared and requirements and timelines.
adopted on time.
Regular reports on ECHA’s activities ECHA fulfilled its 2024 obligations, including Yes
provided to the Management Board. a Management Board exercise to improve
clarity of plans and reports and better linking
strategy implementation to outputs and
indicators.
Quality, internal control and risk ECHA maintained its ISO 9001:2015 and Yes
management frameworks are 14001:2015 certifications and further
implemented. developed its risk management framework,
with a focus on training and awareness
17
https://echa.europa.eu/documents/10162/74925298/final_mb_08_2024_mb_self_evaluation_2024_plan_en.pdf/845
faa2d-7da8-341f-6481-3b4a3b34cb37?t=1713184329505
50
Annual Report 2024
raising.
Agency-wide audit and evaluation The audit and evaluation plan was Yes
plan implemented. implemented with one additional evaluation
conducted upon request by the Commission
(EUON). The number of audit findings (11
see below) includes important and very
important findings. There were no critical
findings in 2024.
Actions foreseen in policies related Actions completed included a mandatory all- Yes
to independence, transparency, staff e-learning, with a focus on conflict-of-
fraud-prevention and data interest prevention and relations with
protection implemented. interest groups; the Management Board
received an annual refresher on ethics.
The focus of data protection actions
concerned procured IT licences and
software, the specific privacy risks involved
with the migration of data to public cloud and
the roll-out of the first AI pilot projects.
The Agency’s organisational model A review of ECHA’s organisation was Yes
reviewed. completed to take account of the new
strategy and our expanding legal mandate.
The recommendations, which addressed
ways of working, strategic prioritisation and
organisational structure will be addressed in
2025.
Interactions with Member States There was increased engagement again in Yes
authorities organised, both through 2024 with the Member States partners
bilaterals and networks (Heads of highlighted by 12 bilateral engagements at
Chemicals authorities meeting). the level of the Executive Director and a
network meeting with the heads of Member
States’ chemical authorities, organised in Q1
2024. These efforts significantly exceeded
the corresponding indicator.
ECHA’s collaboration with other EU ECHA’s overall collaboration with Institutions Yes
agencies, Commission services and and other EU agencies was deepened, as
international bodies is deepened. shown by the collaborative actions and
Review of corresponding outputs presented in the respective
agreements launched and revised activities. A review of the agreements with
as needed. third countries and EU agencies was
conducted, with the implementation of
resulting revisions planned to start in 2025.
JRC-ECHA collaboration agreement The revision of the JRC-ECHA collaboration Yes
concluded. agreement 18 was concluded in Q3 2024.
Regular and structural dialogue Regular engagements took place with the Yes
with ECHA’s institutional partners institutional partners, via bilateral meetings
maintained and further developed or participation institutional events (22
in aftermath of the 2024 European engagements at high level). New
elections. Opportunities for joint stakeholders for the 2024-2029 policy cycle
engagement with other EU/ENVI were mapped and contacts established.
18
https://echa.europa.eu/documents/10162/17206/collaboration_agreement_between_jrc_and_echa_en.pdf/c750cf63
-e9b2-40de-a109-c72a24098952
51
Annual Report 2024
agencies investigated. These efforts significantly exceeded the
corresponding indicator, also due to
increased stakeholders’ interest in engaging
with the Agency.
The five ENVI agencies (ECHA, EMA, EEA,
EFSA, ECDC) jointly introduced their work to
the new European Parliament’s ENVI
committee in December 2024.
Increased Brussels presence for The institutional liaison presence in Brussels Yes
institutional liaison purposes. was increased (ca 9 extended missions).
Indicators Estimate Actual
Number of Management Board plenary MB meetings 4 5
% of documents provided on time as required by RoP 95 83
Percentage of statutory documents adopted on time 100 100
Number of major findings during internal and external audits, no 0 11
reservations in Court of Auditor observations
Discharge granted Y Y
Number of breaches of trust or disciplinary procedure initiated for 0 0
conflict-of-interest management.
Number of high-level meetings conducted with Member States and 12/12 34
European Union institutions
Number of meetings conducted with international organisations and 12 11
third countries (besides IPA and OECD)
Objective 4: ECHA’s communication is effective, transparent, targeted and timely.
Main Outputs Execution Status
New Communications Strategy A new External Communications Strategy Yes
implemented. and Stakeholder Engagement Approach
were developed and implemented in support
of ECHA’s new strategy.
Relations with relevant media Contacts with media were managed Yes
outlets improved and expanded. efficiently and effectively. Highlights for the
year included contacts around the Helsinki
Chemicals Forum (HCF) as well as
engagement with EUObserver, Deutsche
Welle, Euronews, Euractiv, ChemicalWatch
and Politico. Visits from Finnish and Swedish
environmental journalists were also hosted.
Number of social media followers The number of followers across ECHA's social Yes
increased. media channels - LinkedIn, X, Facebook,
YouTube - increased by 21% from 110,500
at 31 December 2023 to 132, 257 at 31
December 2024.
52
Annual Report 2024
ECHA website improved as a key We concentrated on stabilising and Yes
communications channel to all maintaining the website. However, it
stakeholders. suffered a number of outages throughout the
year due to its aging technology and
complicated structure. The future
development of the website will form part of
the Public Portal element of ECHA’s longer
term IT Transformation Project.
Biannual meetings of the Member Two meetings of the network were held Yes
States Competent Authorities (May, September). Working with Member
Communicators Network held and States, we have increased participation
activities reported. during the course of the year with feedback
received being overwhelmingly positive.
Internal Communications Strategy ECHA finalised its Internal Communications Yes
developed and implemented. Strategy to support ECHA’s strategic goal of
investing in people and organisational
excellence.
Consistent staff use of ECHANet ECHANet continued to be the main source of Yes
information for staff on relevant work-
related issues.
Continue cooperation on This work was facilitated through three Yes
communications alignment with workstreams:
sister Agencies and MS.
- the Member State Communicators
Network – which met twice in 2024;
- ECHA's role in the ENVI Agencies Heads
of Comms informal network which met
monthly to ensure coordinated actions
and share relevant information and
experience; and
- ECHA's active participation in the
broader EU Agencies Heads of
Communications & Information Network.
In addition to the identified workstreams,
ECHA was also active in the:
- One Health project with colleagues in the
other ENVI agencies;
- ENVI Instagram account (weekly basis);
- ICOP on Stakeholder Engagement (ENVI
Agencies) including a physical workshop
in November.
Indicators Estimate Actual
Share of neutral and positive coverage of ECHA >85 % 98 %
Website unique visitors/traffic to web content 4.2 M 5 449 176
53
Annual Report 2024
Growth in social media followers 120 K 134 527 19
Unique staff visits to ECHAnet 2.1 M 1 021 668 20
Objective 5: Open and transparent engagement with all stakeholders.
Main Outputs Execution Status
New stakeholder engagement The new engagement approach has been Yes
approach implemented. rolled out across the organisation. This
approach has been used to map
stakeholders relevant for new tasks i.e.
Batteries. An internal Customer Relationship
Management (CRM) pilot was launched in
October, which will report on progress in
early 2025.
ECHA Conference 2024 delivered A first post-pandemic in-person conference Yes
and positively received. under the theme of Shaping Tomorrow was
organised, which saw 300 participants join in
Helsinki with excellent feedback on content
and format.
NGO Dialogues and Accredited Biannual dialogues with non-governmental Yes
Stakeholder Organisations organisations (NGOs) and three introductory
introductory sessions held. sessions for Accredited Stakeholder
Organisations (ASOs) were organised.
Launch Stakeholder Perception The survey project was initiated and Yes
Survey – to provide benchmark for prepared in October for launch in early 2025.
future annual indicators. The results will feed into ECHA’s future
stakeholder interactions, development of
KPIs etc.
Preparation of Eurobarometer We provided input to DG ENV in the Yes
survey question(s). preparation of its 2024 Eurobarometer
Survey which resulted in the inclusion of
specific questions on chemicals relevant for
ECHA.
Indicators Estimate Actual
ECHA engagements with stakeholders 21 200 113
ECHA Conference survey results Positive 4.4 22
19
The projected growth in 2024 was 8.5%. The majority of new followers were gained on LinkedIn, as a result of a
combination of organic growth and successful paid campaigns aimed at attracting new followers.
20
The number of visits to pages by staff was less than half (1.02m) of the projected figure of 2.1m. The initial high
level in Q1 reflects the update of information on the site and the need for staff to check and review which was
reflected as visits. Continued monitoring of the number of visitors will be undertaken to determine the disparity
between projections and actual visits.
21
The recording of stakeholder interactions is still in its developmental phase with the recorded figures for 2024
indicating those meetings undertaken by senior management and the Communications Unit. The figure is expected to
differ in 2025 when reporting is extended following the CRM pilot.
22
Participant rating from the post-event feedback survey, on a scale 1-5.
54
Annual Report 2024
Objective 6: Companies, and in particular SMEs, have the necessary advice to meet legal
obligations.
Main Outputs Execution Status
Questions are timely and effectively 45000 questions were answered by the Yes
answered. network of national helpdesks, with more
than 9000 answered by ECHA.
Topics of broad interest/relevance New FAQs and Q&As were published and Yes
discussed and agreed among all increased efforts were taken to engage and
national helpdesks for harmonised cooperate with the national helpdesks and
advice. other environment agencies.
Preparations initiated to support The ECHA helpdesk received and answered Yes
companies following the revised questions on the new tasks were picked up
regulations under the CSS, e.g., by the Helpdesk. The national Helpdesks
CLP and REACH regulations. were informed by the Commission and the
European Parliament on the CLP revision.
Regular contacts with SME to An action plan was agreed to step up our Yes
understand and address better efforts to support SMEs and will be
their specific needs established. implemented over the next years.
Indicators Estimate Actual
Number of helpdesk questions answered (across all our legal basis) 10 000 9 330
Objective 7: Compliance with legal requirements related to finances, human resources,
procurement, intellectual property and access to documents.
Main Outputs Execution Status
ECHA’s contributions in legal All ECHA contributions in legal proceedings Yes
proceedings made within deadlines. were made within deadlines in seven
proceedings in front of the European Court,
in eight cases in front of the Board of Appeal
and in 18 cases in national courts.
Legal review, advice and training We provided legal review, advice and Yes
provided to ensure sound decisions training to ensure sound decisions on access
on access to documents. to documents. We observed an increase in
access to documents requests. Many
requests were also considerably larger in
scope than in earlier years.
ECHA’s trademarks kept up to date. ECHA’s trademarks were all kept up to date. Yes
Indicators Estimate Actual
Access to documents requests received and concluded 100 145
55
Annual Report 2024
Objective 8: IT operations are efficient, secure and of high quality.
Main Outputs Execution Status
The refresh of end-of-life Progress for this refresh was delivered as Yes
administrative tooling continued. planned in the scope of management
information systems.
The replacement framework The new Management Information Systems Yes
contracts for Management contract was established and awarded as
Information Systems and for planned. The transition to the new IT
managed IT Workplace Services Workplace Services was successfully
established. completed.
A target architecture and roadmap A target architecture and roadmap was Yes
of the administrative/support prepared. The deliverable will be revised
tooling to increase staff productivity regularly to incorporate future changes.
and better support ECHA strategy
prepared.
New Cybersecurity and Information Investments and efforts to meet Yes
Security regulations adopted, and cybersecurity regulation requirements
implementation continued. continued successfully, with a low number of
cybersecurity incidents. All but one incident
was categorized as low or medium level. The
more significant incident, related to a third-
party software vulnerability, was
professionally managed, minimizing impact
and ensuring no ECHA data or systems were
compromised.
User satisfaction surveys The survey took place in November Yes
completed and indicating a high demonstrating high level of satisfaction
level of satisfaction. among the users.
Indicators Estimate Actual
Average availability of key systems >98 % 100 %
High impact security incidents 23 <2 0
Objective 9: IT functions and business processes transformed, modernised and enhanced.
Main Outputs Execution Status
First solution following the new We focused on laying the foundation of the No
modular target architecture modular architecture on which the capabilities
published (DWD). for supporting DWD regulatory obligations are
expected to be deployed. Significant work was
delivered also for producing a solid
understanding of the information flows and
the operational and business capabilities
required to fulfil the DWD deadlines for 2025.
23
Number of successful cyberattacks with very high impact for ECHA (e.g. resulting to loss, leakage, tampering of
important data, systems unavailability).
56
Annual Report 2024
Plans to transition to public cloud As part of ECHA’s IT transformation plans, a Yes
infrastructure and services followed. project to migrate the agency’s IT assets to
public cloud infrastructure was started. This
migration will provide access to modern
technologies and capabilities, such as AI, and
long-term efficiencies across the IT delivery
process.
Data provision services of the Service maintained and delivered according to Yes
organization maintained. the plans.
A coherent data catalogue of data First data catalogue is available. Stewards Yes
products and assets with their appointed for most urgent data product. The
respective stewardship produced. work on this topic will continue in 2025.
Long term (5 years) IT vision, plan A five-year IT plan, outlining the vision, Yes
and roadmap adopted and priorities, and approach for the new
implementation started. architecture, was developed and endorsed.
ECHA systems achieved a 100% availability
rate, surpassing the 98% target, ensuring a
high level of service.
ECHA’s internal horizontal working group for
Artificial Intelligence created guidelines for
the safe use of AI, assessed potential AI use
cases, proposed several pilots, and
coordinated AI initiatives.
New refined and more agile IT A model was developed, which will be first Yes
governance model developed. piloted and refined during 2025 under the IT
Transformation Plans.
First version of ECHA wide design Investments in user experience continued, Yes
system for improving the resulting in the first version of the ECHA
development process and alignment Design System—a comprehensive set of
between solutions developed. guidelines, components, and tools to maintain
consistency in digital product design and
development.
The target enterprise architecture Work on regulatory process tooling area Yes
adopted, and implementation progressed according to the enterprise
started to improve tooling for architecture vision. The goal is to replace the
regulatory processes for internal existing fragmented application landscape
and authority users. with a regulatory-agnostic modular
architecture, capable of serving all current
and future regulatory tasks of the agency.
Indicators Estimate Actual
Long-term (5 years) IT vision, plan and roadmap adopted Yes
Objective 10: ECHA’s budget is implemented in accordance with the objectives set in the
Programming Document and the Financial Regulation.
Main Outputs Execution Status
Annual budget prepared and We effectively managed our financing through Yes
57
Annual Report 2024
implemented in accordance with the close monitoring of uncertain fee income
objectives set in the Programming development. On the final budget size of EUR
Document and the Financial 126.6 million, the Agency reached a 99.5%
Regulation. commitment rate and 87.0% payment rate,
exceeding the targets set. Comprehensive
details on ECHA’s budget management in
2024 can be found in Part II and Annex II of
this report.
Annual accounts prepared and The annual accounts were prepared in a Yes
implemented for ECHA’s timely manner, with a clean audit opinion
Management Board and the relevant attained. The European Court of Auditors gave
EU institutions, in accordance with a clean audit opinion on ECHA's annual
the requirements of the Financial accounts for 2023.
Regulation.
Procurement and contracting The 2024 procurement plan was presented, Yes
activities implemented in adopted and revised by the Management
accordance with the objectives set Board and relevant actions implemented.
in the Programming Document and
the Financial Regulation.
Regular reports provided to the Monthly reports were provided to, and Yes
Commission partner DGs on the continuous communication took place with,
evolution of fee income and budget the Commission partner DGs.
implementation.
We also conducted and delivered a study on
costing of its fee-related services, as
requested by the Commission.
Regular contacts maintained with Two amending budgets were agreed with the Yes
the Commission partner DGs to Commission partner DGs and presented for
agree ways of handling any shortfall adoption by the Management Board.
or surplus arising during the
financial year.
Annual evolution of the transfer of a Annual report presented to the Management Yes
proportion of fees to Members Board Subgroup on Finance, Audit and Risks.
States reported.
Indicators Estimate Actual
Level of budget implementation: Commitment rate. >95 % 99.5%
Level of budget implementation: Cancelled payment appropriation <5 % 0.5 %
rate (including carry-forward)
Processing of payments within legal deadlines >99 % 99.8 %
58
Annual Report 2024
Objective 11: Attract, develop and retain competent and committed staff to implement ECHA’s
mandate, purpose and vision.
Main Outputs Execution Status
Actions under ECHA’s People and We adopted ECHA’s People and Organisational Yes
Organisational Strategy 2024-2028 Strategy 2024-2028 that supports the Agency
implemented. in delivering on its Strategy for the same
period, in line with its goal to invest in people
and organisational excellence and the two
related priorities to develop and empower
people for success and to create optimal ways
of working for the Agency, its bodies, people
and the environment. Key deliverables from
the first year of implementation included the
following:
• In the area of attracting and selecting
people; we adopted a selection plan
based on a robust gap analysis with a
view to both existing and upcoming
tasks for the Agency, the onboarding of
new selection tools and the further
investment in employer branding
through participation in different job
fairs.
• With respect to a positive people
experience and engagement, we
ensured career development
opportunities for staff through regular
career enhancement calls; our mental
health working group delivered
meaningful campaigns and staff
cohesion was supported through several
staff events, including our first corporate
day after the pandemic.
• People development was further
promoted through a dedicated learning
and development plan that addressed
current and future needs, paving the
way for onboarding new tasks allotted to
the Agency. We also adopted a new
policy on capacity building with external
partners and initiated a pilot project
thereunder.
• Finally, we supported the organisation’s
ongoing development through the
conduct of an organisational review
exercise and dedicated contribution to
the Agency’s AI working group.
At the end of 2024, all KPI’s in the area of HR
were met and the staffing plan filled at 97.2%.
ECHA’s Wellbeing Action Plan 2023- See under objective 12 below. Yes
2024 implemented in conjunction
with ECHA’s Joint Committee for
Health and Wellbeing.
59
Annual Report 2024
ECHA’s Diversity and Inclusion We implemented our 2024 action plan which Yes
Action Plan 2023-2024 included general awareness raising around
implemented. key Diversity and Inclusion topics through
events, articles and training. To support the
specific focus on gender balance at
management level we onboarded
management representatives to our internal
D&I Working Group, discussed best practices
and challenges in fostering a diverse and
inclusive work environment with the
Management Team, and delivered training
courses on unconscious bias to managers and
team leaders. A slight increase is observed in
the representation of women in middle and
senior management compared to 2023.
Nationality balance of ECHA staff is
comparable to 2023 with Finns representing
nearly a third of all staff.
Regular communication with ECHA’s Regular meetings between management and Yes
Staff Committee to maintain a the Executive Director were held with the Staff
healthy working culture and positive Committee. Elections were also successfully
relations and dialogue. held for a new staff committee in December.
Indicators Estimate Actual
Turnover of Temporary Agents <5 % 1.5%
Turnover of Contract Agents <10 % 0.8%
Percentage of Establishment Plan posts filled 95 % 97.2%
Objective 12: A safe, productive and healthy physical work environment for staff and guests.
Main Outputs Execution Status
ECHA’s Wellbeing Action Plan 2023- ECHA’s Wellbeing Action Plan 2023- 2024 was Yes
2024 implemented in conjunction progressed, by the Agency’s Joint Committee
with ECHA’s Joint Committee for for Health and Wellbeing and numerous
Health and Wellbeing. implementation measures were undertaken
throughout the year.
Following up on a 2023 analysis on optimising
the use of our office building and Conference
centre, a pilot project was initiate, to plan for
testing new ways of working.
ECHA’s Environmental Work We successfully organised meeting services Yes
Programme 2023-2025 for approximately 400 events and official
implemented. meetings, with 36 600 participants joining
online through Webex, and approximately 5
300 visitors hosted in person in our premises.
Against this backdrop, we also continued to
work towards our aim to reduce CO2
emissions from both staff travel and building
operations. Our 2023-2025 environmental
60
Annual Report 2024
work programme was coordinated and
monitored effectively (more information in
Part II and Annex VII).
Actions related to ECHA’s ISO We obtained recertification of the Agency’s Yes
14001:2015 and EMAS certifications International Organisation for Standardisation
co-ordinated. (ISO) 14001:2015 and EU Eco-Management
and Audit Scheme (EMAS) until 2027.
Guidelines for the implementation of the ISO
20121:2012 standard on event sustainability
management systems were developed and
issued during 2024.
Indicators
N/A
Objective 13: Implement the Regulation on Serious Cross-border Threats to Health (SCBTH).
Main Outputs Execution Status
Internal procedures in place to The preparation of internal procedures was No
enable delivery on the tasks started in 2024 and will be concluded in 2025.
allocated.
Approach confirmed and co- Agreement was signed in November 2024. A Yes
ordinated with Commission and contribution agreement with the Commission
other agencies. was concluded setting the basis for ECHA’s
preparation to deliver on this new task. ECHA
participated for the first time in simulation
exercises with other EU and national bodies to
increase EU preparedness for SCBTH.
Indicators
N/A
Objective 14: Support development and implementation of new legal requirements.
Main Outputs Execution Status
Contribution provided to ECHA provided input, as requested, to Yes
Commission’s work on CSS ongoing legislative processes with impact on
implementation and REACH ECHA’s tasks executed, in particular in the
revision. context of the ‘one substance, one
assessment’ (OSOA) package.
Indicators
N/A
61
Annual Report 2024
Part II. Management
Management Board
The Management Board (MB) provides strategic direction and governance to ECHA to enable the
Agency to deliver on its purpose and vision and meet the expectations of its stakeholders.
In 2024, the MB saw changes in its leadership, with the election of its new Chair, Sofia Zisi
(Greece) in September and its new Deputy-Chair, Per Ängquist (Sweden) in December. As part
of its commitment to continuous improvement, the MB conducted a self-evaluation in 2024,
reviewing its own processes, decision-making and governance. The self-evaluation resulted in a
few targeted improvement actions, without any major change in the MB’s way of working 24.
With a view to ensuring the workability of ECHA’s committees, the MB decided in 2024 to increase
the payments for REACH restriction rapporteur work in RAC and SEAC. Regarding the Board of
Appeal (BoA), the MB decided in December 2024 to transition the ECHA BoA to an ad hoc
structure, composed of members appointed by the MB, based on a list proposed by the
Commission, who will not be staff members of ECHA.
During 2024, the MB continued closely monitoring the legislative and policy developments with
an impact on ECHA’s mandate and resourcing, including the new tasks assigned to ECHA. It also
continuously oversaw the risk management processes, including regularly reviewing the Agency
Risk Register and specific reporting on IT security, as well as obtaining assurance that risks are
properly identified, assessed, and mitigated.
The MB adopted all documents required by law in line with the applicable rules and regulations.
In its capacity of Appointing Authority, the MB took the necessary decisions in all staff matters
for the functions reporting directly to it (Executive Director, members of the Board of Appeal),
including the annual performance appraisals.
Major developments
Following the 2024 elections, the EU set new political priorities focusing on sustainable
prosperity, security, and social fairness. ECHA closely monitored these evolving priorities and
engaged with stakeholders to ensure clarity and readiness for necessary changes. As an EU
decentralised agency, ECHA is also expected to reduce administrative burdens, foster
competitiveness, and maintain high standards of health and environmental protection.
Throughout 2024, ECHA supported decision-makers in negotiations on the One Substance, One
Assessment package, which bring significant new tasks. Anticipating the future ECHA Basic
Regulation, ECHA contributed to the Commission’s preparatory work to strengthen governance
and streamline operations. Additionally, ECHA tracked political developments related to the
simplification of REACH and clarification of PFAS regulations, preparing to provide scientific-
technical input as needed. Amid resource constraints, ECHA focused on enhancing internal
competence and capacity, collaborating with Member States to address gaps and align with the
EU’s vision for a sustainable future.
In 2024 ECHA started the implementation of its new Strategy 2024-2028, which, according to
the perception of its Management is on a good path, well communicated to staff with values well
lived up to and upheld. In line with ECHA’s priority to ‘Ensure that our organisational model is
ready to support delivery of our current and future mandate’, ECHA undertook an organisational
review in 2024. The organisational review was conducted to address the evolving nature and
24
MB/M/04/2024 final:
https://echa.europa.eu/documents/10162/91846726/mb_m_04_2024_minutes_mb75_en.pdf/9b697143-04ee-8717-
92b6-a85fe469420c?t=1734527244500.
62
Annual Report 2024
increasing complexity of ECHA’s tasks and mandate, necessitating a strategic approach to
optimise performance and integrate new responsibilities. Following the last review in 2018, which
led to structural changes effective from January 2019, it became clear that further adjustments
were needed to ECHA’s ways of working and organisation, underpinned by internal and external
feedback. The recommendations, which addressed ways of working, strategic prioritisation and
organisational structure will be addressed in 2025.
Budgetary and financial management
Financial management
ECHA effectively managed its financing in 2024, by closely monitoring the development of fee
income and the overall financing position. By the end of the year, the financial operations
reached a 99.5 % commitment rate and 87.0 % payment rate, notably exceeding the targets
set. The European Court of Auditors gave a clean audit opinion on ECHA's annual accounts for
2023 and carried out the first part of its audit for the financial year 2024 under a new audit
team.
Details on ECHA’s budget information and management in 2024 can be found in Annex II.
Delegation and sub-delegation of the powers of budget implementation to
agency’s Staff
ECHA maintains a system of operational and financial delegations as part of its Integrated
Management System, which allows to effectively manage delegations and sub-delegations,
taking into account the risk level of the particular process.
Human Resources (HR) management
Human resources management
In 2024, ECHA adopted and started to implement the People and Organisational Strategy 2024-
2029. Our joint efforts in running selection procedures efficiently and investing in employer
branding led to a high rate of filled establishment plan posts (97.2 %) with a low Temporary
Agent turnover (1.5 %) rate. We maintained a strong focus on staff wellbeing through delivery
on our respective action plan, in close cooperation with ECHA’s Joint Committee on Health and
Wellbeing. In addition, the Diversity and Inclusion Action Plan was further implemented.
Strategy for efficiency gains
ECHA’s Integrated Management System Strategy and Framework has demonstrated its
effectiveness in achieving the Agency’s strategic goals and priorities throughout 2024. The
results of the annual benchmarking exercise (full results available in Annex IV) conducted in
accordance with the Commission’s requirements indicate efficiency gains in the Agency’s
administration. The results show a decrease of 2.6% in the staff involved in administrative
support and coordination and increase of 2.1% and 0.5% in the staff involved in operational and
neutral tasks, respectively.
In the realm of IT, ECHA continued the development of its new enterprise architecture
throughout 2024. This approach focuses on streamlining business solutions through modular
architecture, enabling faster adoption of new regulatory processes. The governance of ECHA's
IT portfolio was also revamped, to further accelerate the transition towards the target
architecture.
63
Annual Report 2024
Additionally, ECHA continued its efforts to digitalise its administrative processes in 2024. As a
concrete example of this work, the Agency completed the incorporation of electronic signatures
to document workflows through the implementation of EU Sign, a qualified electronic signature
tool developed by DG DIGIT. This tool allows electronic signature of all documents signed by the
Agency, reducing both paper and postal costs as well as time spent by relevant actors to process
original documents, thus gaining efficiency.
Assessment of audit and retrospective evaluation results during the reporting
year
Retrospective evaluations
In 2024, ECHA performed the following retrospective evaluations following the criteria and
methodology as stipulated in the Better Regulation Guidelines 25 :
• Retrospective evaluation of ECHA’s HR strategy 2019-2023. Upon request of the
Management Board, this ex-post evaluation analysed the degree of effectiveness,
relevance, efficiency, proportionality, coherence, added value and sustainability of the
ECHA’s HR strategy. The lessons learnt will be used for the implementation plan of the
current People and Organisational strategy.
Main highlights from the evaluation are presented below:
It could be overall concluded that the objectives of the HR Strategy have been
achieved to a large extent. The HR strategy has contributed to developing ECHA’s
competence base for current and future tasks, building a high performing and flexible
environment, promoting staff engagement by facilitating career development and
enhancing management and leadership capabilities. It could also be concluded that
ECHA’s HR strategy has brought added value to ECHA in alignment to ECHA’s long
term strategy 2019-2023.
ECHA’s competence map is well used in various HR processes, such as identifying
competence gaps and training needs. The use of the competence map across ECHA and
in the resource planning and allocation exercise could be further strengthened.
Following the challenges of the pandemic, ECHA has progressed towards creating a more
flexible work environment and better work-life balance.
Staff engagement has been promoted in various ways, with a high use of internal career
development opportunities throughout the years, decrease in the interims’ support and
developing an employer brand for ECHA.
Management and leadership capabilities have overall improved over the years via
coaching, training and other management practices, which is visible in the trends of the
Staff survey with regards to trust in Senior management and job motivation. Employer
image, diversity and inclusion have also a very good perception by staff. Fair
rewarding of staff however is an area where further efforts are needed. ECHA’s HR
Unit has taken actions on increasing the transparency of the reclassification process,
however it cannot yet be judged if those actions have been effective.
Despite the complexities and legislative constraints, ECHA has been able to achieve
certain level of synergies and efficiencies in its HR services and overall in its
horizontal activities. ECHA compares with other ENVI agencies as the Agency with the
25
http://ec.europa.eu/smart-regulation/guidelines/tool_42_en.htm
64
Annual Report 2024
lowest proportion of its HR staff to total staff and the lowest proportion of “neutral
staff” to total staff, which includes posts in horizontal services, such as finance,
procurement, quality management, linguistics etc. Maintaining such a low proportion of
HR and overall horizontal services staff however bears the risk of decrease in the
staff wellbeing and ECHA not being able to manage the increasing workload.
• Second interim retrospective evaluation of European Union Observatory for
Nanomaterials (EUON). Upon request of the Commission, this second interim ex-post
evaluation analysed the degree of effectiveness, relevance, efficiency, proportionality,
coherence, added value and sustainability of EUON. A comparison with the results from
the previous evaluation of EUON in 2019 was made and the trends followed to conclude
on the developments from 2019 until 2024. The lessons learnt will be used by the
Commission to decide on the future of EUON. The evaluation is available on the EUON
webpage 26.
Internal Audit Service (IAS)
The Internal Audit Service (IAS) of the Commission did not conduct audits in 2024 at ECHA. IAS
has closed all pending actions from earlier audits.
Internal Audit Capability (IAC)
The Internal Audit Capacity (IAC) conducted four assurance audits (one finalised in January
2025) with the objective of assessing and providing reasonable assurance on the regularity and
the quality of internal control systems applied as well as efficiency and effectiveness of the
processes.
The audit “Helpnet” resulted in three important recommendations:
• Establish long term planning to anticipate and prepare for the future challenges of the
national helpdesks and to ensure that Helpnet members are systematically consulted on
the critical areas necessitating EU-level harmonisation.
• Establish indicators to assess efficiency and effectiveness of the Helpnet activity.
• Continue to activate and engage the Helpnet members.
The audit “Quality and reliability of data in ECHA reporting” resulted in one very important
recommendation:
• Use the clarified definitions for indicators in a consistent way in all reports. To enhance
audit trail of the data source and calculation of the main indicators and figures in the
Annual activity report, add to the ECHA-level indicator table a link to the data source and
instructions how to retrieve the data. Keep the data source (report) at least for the main
data in annual corporate reports to ensure an audit trail (follow the good practice for
financial data by the Finance Unit).
And two important recommendations:
• To comply with ECHA’s Integrated management system strategy and framework and to
establish clear responsibilities and accountability for numerical correctness, consider
ways how to
o assign designated staff member to a reporting task
o document validation of the most relevant data in ECHA's main corporate reports.
26
View article - European Observatory for Nanomaterials: https://euon.echa.europa.eu/view-article/-
/journal_content/title/new-report-evaluates-the-performance-of-euon
65
Annual Report 2024
• Develop further indicators and corporate reporting
The audit “Testing proposal examination process under Dossier Evaluation” resulted in one very
important recommendation:
• Inform the Commission of the current limitations and unclarities of the legal text to
support its improvement in the context of the foreseen revision of REACH.
Improve the testing proposal examination process.
Provide a transparent overview of the status of the testing proposal examination process
including compliance with the legal deadline.
Continue to analyse the reasons for the backlog TPs and to identify types of TPs where
agreed principles by ECHA management and Member States Committee would help to
conclude TPs.
Calculate the needed resources to improve the TPE process (see also recommendation 5
for specific expertise) and remove the backlog of pending TPEs and aim to assign
sufficient resources to remove the backlog.
And four important recommendations:
• Develop further measures to ensure consistency in the Testing proposal examination.
Consider how to improve the monitoring and reporting of the cases. Review IUCLID and
submission process, including guidance to clarify the process (after changes to the legal
text).
• Improve communication on the Testing proposal examination process to stakeholders.
• Identify and collect indicators and statistics to assess efficiency and effectiveness of the
Testing proposal examination process.
• Ensure the TPE team has the necessary access to expertise on:
o Read-across assessment
o regulatory/ policy issues with complicated TPs
o access to PBT and ED networks for consultation
The audit “Environmental management” did not result in any critical, very important or important
recommendations.
The Agency follows up these recommendations with corresponding actions.
For earlier audits, the Internal Audit Capability conducted two follow-up audits (one finalised in
February 2025) to verify the implementation of the action plans, concluding that 1 very
important and 1 important action are still being implemented.
European Court of Auditors (ECA)
In their statement of assurance 27, the European Court of Auditors (ECA) concluded that the
accounts of the Agency for the financial year 2023 present fairly, in all material respects the
financial position of the Agency at 31 December 2023, the results of its operations, its cash
flows, and the changes in net assets for the year then ended, in accordance with its Financial
Regulation and with accounting rules adopted by the Commission’s accounting officer. These are
based on internationally accepted accounting standards for the public sector.
The revenue and payments underlying the accounts for the year were also legal in all material
27
https://www.eca.europa.eu/ECAPublications/SAR-AGENCIES-2023/SAR-AGENCIES-2023_EN.pdf
66
Annual Report 2024
aspects.
The Court did not make any observations regarding the financial year 2023 and there are no
observations open from previous years either.
Follow up of recommendations and action plans for audits and evaluations
The follow up of the retrospective evaluations from 2023 and namely ECHA’s financial model,
ECHA’s Committees 28 (RAC, SEAC and MSC) and ECHA’s Board of Appeal 29 show that many of
the recommendations are in progress. For RAC and SEAC in particular the actions taken to
increase the capacity of the Committee, such as increasing the rapporteurs’ payment rate in
June 2024, have proved to be effective 30. Some of the recommendations are linked to potential
legislative changes which may be introduced with the Commission’s announced proposal for an
ECHA Basic Regulation.
The follow-up of the evaluations performed in previous years showed that most of the
recommendations on the retrospective evaluations have been implemented. The follow up
includes the following evaluations performed in the last three years: SCIP database (Substances
of Concern In articles as such or in complex objects (Products) established under the Waste
Framework Directive (WFD)) 31, EU Chemicals Legislation Finder (EUCLEF) and the EU
Observatory for Nanomaterials (EUON).
Follow up of recommendations issued following investigations by the
European Anti-Fraud Office (OLAF)
N/A
Follow up of observations from the Discharge authority
In accordance with Article 262 of the Financial Regulation and Article 107 of the Financial
Framework Regulation and the Financial Regulation of the European Chemicals Agency (ECHA),
the Executive Director of ECHA shall take all appropriate steps to act on the observations
accompanying the European Parliament's discharge decision and on the comments
accompanying the recommendation for discharge adopted by the Council, and at the request of
the Discharge Authority, report on the measures taken in the light of those observations and
comments.
ECHA’s follow up report of the discharge 32 provides an overview of the relevant observations and
recommendations from the European Parliament discharge 33 of 11 April 2024 for the financial
year 2022.
In summary, there were six recommendations from the European Parliament, whose
28
https://echa.europa.eu/documents/10162/17086/retrospective_evaluation_of_committees_report_en.pdf/e491f353-
1e6e-8616-8990-48db2fed0056?t=1695807929141
29
file://echa/data/users/u09175/Roaming%20Profile/Downloads/ex_post_evaluation_board_appeal_en%20(6).pdf
30
https://echa.europa.eu/documents/10162/74925298/final_mb_07_2024_decision_transfer_fees_ms_en.pdf/6eb9f27
3-3bf8-3cb8-d5f7-97f33003789a?t=1718633914154
31
SCIP retrospective evaluation:
https://echa.europa.eu/documents/10162/6205986/scip_evaluation_report_en.pdf/2c677149-e876-f2b1-0ba7-
3daca0a419ef?t=1665556373094
32
ECHA discharge follow up 2022:
https://echa.sharepoint.com/sites/1203/120301/Forms/AllItems.aspx?id=%2Fsites%2F1203%2F120301%2F12%2E0
3%2E01%2E02%20MB%20Meetings%2F2024%2FMB75_26-27_Sept%2F02_Docs%2FAPC%2E01_Follow-
up_discharge_2022_recommendations_MB_29_2024%2Epdf&parent=%2Fsites%2F1203%2F120301%2F12%2E03%2
E01%2E02%20MB%20Meeting
33
https://oeil.secure.europarl.europa.eu/oeil/en/document-summary?id=1782930
67
Annual Report 2024
implementation is either ongoing or completed.
Environment management
Environmental and sustainability management
The 2024 objectives for environmental management at ECHA aimed at improving ECHA’s
environmental performance as laid down in ECHA’s environmental policy (POL-0022) and to pave
the way towards achieving climate neutrality by 2030. This was achieved through the
implementation of ECHA’s environmental work-programme and by actively promoting
sustainability with our environmental management system (EMS).
ECHA’s strategy is embedded in ECHA’s EMS where we aim to be a trusted chemicals agency,
we respond to emerging challenges and changes in our legal landscape, and we actively
communicate and engage with our stakeholders. Improvements and innovation in ECHA’s EMS
are achieved through monitoring and verification, through process and legislative updates and
by learning about developments with our stakeholders, particularly with other EU Institutions
and Agencies.
Environmental objectives and indicators
Environmental Objectives 2023-25 Target Result in Achieved
(Benchmark year: 2019) 2024
Building CO2 emissions 20% 75 % decrease Yes
Travel (meeting participants) CO2 emissions 50% 42 % decrease No
Travel (staff missions) CO2 emissions 50% 56 % decrease Yes
Through the continuous monitoring, reporting and verification of ECHA’s EMS, the CO2 reduction
targets for staff travel and building emissions were met. The emissions target related to travel
of meeting participants attending ECHA’s Committees was not met in 2024. This is primarily the
result of the increased demand for in-person meetings to meet business needs, with this risk
highlighted in the EMS audit report by the IAC. Nonetheless, it is considered that a 42%
reduction, in a context of increasing business demands, is noteworthy. In addition, to partly
mitigate the environmental impact of ECHA’s Committees, guidelines for sustainable meetings
were issued in 2024 with a view to future ISO certification.
Furthermore, ECHA identified two environmental indicators that contribute to the Agency’s CO2
footprint. Whilst including new indicators increases ECHA’s total carbon footprint, it allows us to
be comprehensive and transparent in our reporting which enables the Agency to better manage
how we will mitigate our impact on the environment. The two new indicators related to emissions
generated through hotel nights from ECHA staff travel, and the impact of teleworking were added
to the calculation and reporting of our carbon footprint.
68
Annual Report 2024
ECHA’s EMS it is subject to regular audits to ensure that it performs according to our objectives.
In addition to the assurance audit of ECHA Environmental management system conducted by
ECHA’s IAC, four other audits took place in 2024: the ISO 14001 certification Audit, the EMAS
Verification audit and two internal audits. The audits did not identify any non-conformities or
critical, very important or important recommendations, and ECHA’s ISO certificate and EMAS
registration were both renewed.
ECHA made progress in 2024 on greener and more sustainable procurement, when we
strengthened the minimum environmental requirements that companies must meet to deliver IT
services and now request evidence of compliance with the relevant standards.
Achieving climate neutrality
To achieve carbon neutrality by 2030, ECHA will need to compensate the unavoidable residual
greenhouse gases (GHG) emissions. Planning for this this began in 2024 against the legislative
provisions of the forthcoming CRCF Regulation, when ECHA initiated a pilot project on carbon
removals. The CRCF will provide the legal certainty to purchase carbon credits through certified
carbon removal schemes. Working with DG CLIMA and Finnish Centre for Economic
Development, Transport and Environment the pilot project will allow ECHA to explore the
possibility to compensate part of the Agency’s residual emissions using a responsible scheme,
whilst avoiding reputational damage.
Communicating with stakeholders
Finally, to promote and implement ECHA’s environmental objectives, over 30 training and
internal communications activities were undertaken during 2024 to promote climate awareness
actions such as Earth Day, EU Green week and the Baltic Sea Day.
Within the EU Institutional landscape, ECHA published the EU Agencies’ Network “Charter on
greenhouse gases (GHG) reduction and responsible environmental management”, which reflects
ECHA’s environmental policy and objectives. To ensure good cooperation, communication and
knowledge sharing throughout the year with our EU partners, ECHA participated to 10 events
virtually. The events were organised by external stakeholders such as the Groupe
Interinstitutionnel de Management Environmental (GIME) and the EUAN Greening Network (GN).
69
Annual Report 2024
EU Institutional information sessions and ad-hoc meetings
ICTAC & GN Joint meeting on EMAS
GN Lecture on EIT Climate KIC
PDN Meeting on sustainability reporting
GN & NAPO Diversity and Inclusion in sustainability
GN EMAS DE Advisory Board: Sustainability reporting under the CSRD
GN Carbon compensation: Presentation by Climeworks and DG CLIMA
GN Annual plenary meeting with external speakers: Vice-chair ICCP, DG
HR - GIME chair, COMM & ECHA.
GN EMAS related good practice
GIME Climate neutrality of the EU Institutions (ECHA presentation) - Twice.
Assessment by management
Based on the information in the Section II, no significant weaknesses or gaps that may threaten
the achievement of ECHA’s objectives were identified. An overall conclusion taking into account
the findings from the internal control assessment is available in Part III.
70
Annual Report 2024
Part III. Assessment of the effectiveness of
the internal control systems
Effectiveness of internal control system
Compliance and performance of ECHA under the Integrated Management
System Strategy and Framework
The purpose of the annual internal controls assessment is to give reasonable assurance that
ECHA’s management system is functioning, continuously improved, and that the objectives set
out in Article 30 of the ECHA Financial regulation are met, namely: (I) effectiveness, efficiency
and economy of operations; (ii) reliability of reporting; (iii) safeguarding of assets and
information; (iv) prevention, detection, correction and follow-up of fraud and irregularities; and
(v) adequate management of risks relating to the legality and regularity of the underlying
transactions.
The reference for the assessment is ECHA’s Integrated Management System Strategy and
Framework, (POL-0001) which supplements the financial regulation and aligns with the
principles and guidelines set out by the European Commission (in the areas of internal control
and programming) and with the ISO 9001:2015 and ISO 14001:2015 standards.
The assessment is based on a wide range of sources, such as internal and external audits,
retrospective evaluations, risks, non-conformities, complaints, appeals, financial, operational,
IT, environmental and HR reports, complemented with insights from self-assessments of
managers, staff and stakeholders’ surveys. Internal control surveys were conducted to capture
the self-assessment of Directors and Heads of Units with regard to the functioning of the ECHA’s
management system. Stakeholders’ input was captured in the stakeholders survey and various
retrospective evaluations and audits. Staff perception was captured in the staff survey (latest
from 2023) and other internal reports and events. All sources mentioned above were analysed
and triangulated to derive conclusions.
Following the recommendations from the IAS audit on ‘Budget preparation, monitoring and
reporting’ in 2023, ECHA analysed the whole exceptions register. The detailed conclusions from
the analysis of the exceptions register as well as the trend between 2023 and 2024 are available
in the internal controls assessment for the year 2024.
For 2024, the assessment confirms that the Integrated Management System (IMS) is effective
and functioning as intended. All directors and most middle managers agree that management
commits to the core principles. Also, most of the detailed components are fully present and
functioning (8 out of 12), while areas identified for improvement are not considered major, or
critical, deficiencies of the whole IMS or about the objectives of Article 30 of the ECHA Financial
Regulation. Details of the assessment are available in the next section. Improvement work is
either ongoing or planned for 2025.
In terms of costing the controls, the Agency follows the definition in the General Financial
Regulation 34 of the EU, according to which ‘control’ means ‘any measure taken to provide
reasonable assurance regarding the effectiveness, efficiency and economy of operations, the
reliability of reporting, the safeguarding of assets and information, the prevention and detection
and correction of fraud and irregularities and their follow-up, and the adequate management of
the risks relating to the legality and regularity of the underlying transactions, taking into account
34
Financial Regulation applicable to the general budget of the Union: https://op.europa.eu/en/publication-detail/-
/publication/e9488da5-d66f-11e8-9424-01aa75ed71a1
71
Annual Report 2024
the multiannual character of programmes as well as the nature of the payments concerned’.
Controls may involve various checks, as well as the implementation of any policies and
procedures to achieve the objectives. Based on an approximation of the resources deployed in
the units responsible for governance, human resources and financial management, as well as
the average salary costs, the cost of controls as a percentage of the total budget are estimated
to be around 2.8 % which is lower than the previous year, when the percentage was 3.4%.
The summary from the internal controls assessment as per the principles and characteristics of
each component is covered in the next section below.
Risk management
Risk management is an integral part of ECHA’s Integrated Management System. The risks, that
were identified as possibly jeopardising the achievement of the objectives defined in the
Programming Document, were followed up regularly and a more detailed assessment was carried
out every four months during the year. In 2024, ECHA further developed the implementation of
the internal framework for addressing risk management in ECHA through the introduction of
directorate-level risk registers. Regular updates were given to the Management Board and
specific reporting continued on the IT-security related risks.
Transparency, accountability and integrity
Throughout 2024, the Agency lived up to its values of transparency and integrity, ensuring
continued public and stakeholder trust in the impartiality and objectivity of ECHA’s work.
The decision-making processes of the Agency are designed to be clear, open and to ensure a
balanced outcome based on a reasoned scientific approach. Information on the intentions of
ECHA and the Member States – for example, to look into substances or create dossiers – is
available online, so companies have access to the data they need to make informed business
decisions.
Accredited stakeholder organisations may participate in scientific meetings as observers, except
where confidential business information requires sessions to be closed. This gives them a chance
to witness the debate and decision-making process and, where appropriate, express their views.
Where consultations take place, the comments received are discussed and addressed. The
reflections, minority opinions and conclusions of ECHA’s scientific committees are recorded in
opinions and minutes, and these are published online.
ECHA maintains the world's largest regulatory database on chemicals. The database provides
transparent information on the chemicals used in Europe today. In early 2024 ECHA launched
ECHA CHEM, which is ECHA’s new public chemicals database launched. Initially, it includes data
that companies have submitted in their REACH registrations. Over the coming years, ECHA will
gradually transfer the data it makes publicly available from their current location (Search for
chemicals) to ECHA CHEM.
72
Annual Report 2024
Prevention of conflicts of interest
Based on a thorough risk assessment of its activities, the Agency has identified the processes
and sub-processes that require conflicts of interest to be managed. Conflict of interest checks
are performed for more than 30 processes, sub-processes or process steps, including the main
operational processes of the Agency.
In all these processes, a review of the annual declarations of interest is performed by the process
owner each time a task is assigned to a staff member, while for some sensitive processes this is
complemented with a case-specific declaration of no interest by the staff member.
If there is a potential conflict, the case is assigned to a different staff member. The approach is
documented in detailed work instructions and guidance is available for those managing the
interests to help them deal with individual cases. As a result, no cases of actual conflicts of
interest among ECHA staff, affecting the output of the Agency were identified in 2024.
For the ECHA bodies, all members are assessed against the generic exclusion criteria agreed
upon by the Management Board, at the time of their appointment. Once they take up their
function, their annual declarations of interest are reviewed by the respective Chair and published
on ECHA’s website.
Before each meeting of an ECHA body, specific declarations for items on the agenda are collected
and documented in publicly available minutes together with the mitigating measures imposed.
As most of the members of ECHA’s bodies are Member State public officials, the majority of the
conflicts of interest declared by the members concerned involvement in preparing dossiers
submitted by their Member State competent authority. In all such cases, the members concerned
were not allowed to participate in the voting on such dossiers.
Post-employment
Members of staff must notify new occupational activities for the first two years after leaving the
service of the Agency. ECHA can forbid the new activity or impose conditions.
In 2024, sixteen (16) staff members left ECHA: four (4) of them went to work for another EU
institution, body or Agency. One (1) staff member moved to a national public administration or
international organisation. Three (3) staff members moved to the private sector or started self-
employment and, in one (1) of these cases, the Agency deemed it necessary to impose specific
conditions due to the nature of the occupational activity or the role of the individual within their
new occupation.
In the remaining eight (8) cases, ECHA has not (yet) been informed about a new occupational
activity, as the departure was due to retirement, termination of contract or death of a staff
member. None of these cases concerned a member of senior management.
An overview of the post-employment decisions of all former senior managers is published on
ECHA’s website, including their names, date of departure, positions, their foreseen new
occupational activities, and the outcomes of ECHA’s assessments 35.
No breaches of trust or disciplinary procedure were initiated for conflict-of-interest management.
Conflict of Interest Advisory Committee
The Conflicts of Interest Advisory Committee (CoIAC) is an advisory body in the context of
35
https://echa.europa.eu/documents/10162/13559/post-employment_senior_managers_en.pdf/8567fc1f-1631-05fe-
eceb-8817a0e110d1
73
Annual Report 2024
ECHA’s Procedure on Prevention and Management of Potential Conflicts of Interest. The
Committee is available to the Management Board, the Committees, the Forum and the Executive
Director for advice on matters related to potential conflicts of interest of ECHA staff or members
of the Agency’s bodies.
The Committee comprises three members: Per Ängquist, appointed by the Management Board
from among its members, Madeleine Healy, a Senior Compliance Expert from the Single
Resolution Board, appointed as an external expert, and Minna Heikkilä, Head of ECHA’s Legal
Affairs Unit as Chairperson. The external expert was newly appointed in 2024, following a public
call for expression of interest. Three alternate external experts were also appointed at the same
time.
In 2024, the CoIAC delivered five opinions. On 12 March 2024 the CoIAC advised on the
prospective activity of a recently retired former Head of Unit of ECHA. The CoIAC did not find
any reason justifying objections to this activity. On 9 April 2024 the CoIAC gave its advice to the
Executive Director concerning an analysis of ECHA’s Policy on Prevention of Conflict of Interests
and implementing rules with a view to the expanding role and mandates of the Committees and
the actors involved around the Committee work. In July 2024, the CoIAC further advised on the
application of the Policy in the context of the selection and appointment of the co-opted members
for the Committees for Risk Assessment (RAC) and for Socio-economic Analysis (SEAC).
On 29 November 2024, the CoIAC convened for its annual meeting where two further requests
for advice from the Executive Director and from the Chair of the Management Board were
discussed. These related to the appointment of members of the RAC and to the perception of
conflicts related to public procurement. The advice in both cases was further discussed and
concluded in written procedure on 9 December 2024.
Ex-post controls
In line with the Procedure on Prevention and Management of potential Conflicts of Interest, ECHA
may undertake ex-post controls to guarantee the effectiveness of the procedure.
A sample check on 11 annual declarations (DoI) submitted by the chairpersons of the ECHA
bodies and expert groups revealed that all of them were in place, accurate and sufficiently
complete to allow for effective conflict of interest prevention and management. However, while
the internal DoI tool for submitting and verifying the annual declarations of interest of the ECHA
staff contained an updated DoI for the four chairpersons of the MSC, RAC, SEAC and BPC, on
the ECHA website an older and outdated version of this declaration was made publicly available.
This however did not undermine the process of verifying conflicts of interest, as an up-to-date
DoI was available for that purpose, but it did not give stakeholders a transparent view on the
DoI as required.
In addition, ECHA’s Internal Audit Capability took sample checks during her audit of the testing
proposal process to verify that conflict of interest checks were performed for ECHA colleagues
for 2 testing proposal dossier examinations. It was confirmed that indeed such checks are
systematically made for all testing proposal dossiers.
Fraud prevention
By design, the Agency’s internal control systems contain fraud prevention, with an emphasis on
critical areas such as financial transactions, procurement and selections.
ECHA’s Code of Good Administrative Behaviour 36 is well communicated to all staff members.
36
https://echa.europa.eu/documents/10162/13559/code_of_good_administrative_behaviour_en.pdf/a4aa94f7-f631-
43d6-8c28-77a10a0d0720
74
Annual Report 2024
Management Board decision 30/2009 of 23 April 2009 stipulates the terms and conditions for
internal investigations in relation to the prevention of fraud, corruption, and any illegal activity
detrimental to the Communities’ interests.
Guidelines for whistleblowers were first adopted in 2015 and updated in September 2018.
Through these guidelines, ECHA ensures that its employees can always highlight any action
which goes against the public interest.
The ECHA Anti-Fraud Strategy 37 was revised by the ECHA Management Board in December 2022
and includes a focus on maintaining and further developing the anti-fraud culture in the Agency
and regularly reviewing key policies and procedures. In autumn 2024 a mandatory all-staff e-
learning was organised, with a focus on conflict of interest prevention and relations with interest
groups, while also the Management Board members received an annual refresher on ethics.
Data protection
The Data Protection Officer is an independent function within the Agency, who advises the
Agency and staff on compliance with privacy laws and regulations. He keeps the required records
of processing operations centrally and acts as the liaison with the European Data Protection
Supervisor.
In 2024, the focus areas of support concerned the regular review of data protection aspects of
procured IT licences and software, the specific privacy risks involved with the migration of ECHA
data to public cloud and the roll-out of the first AI pilot projects. Actions have also been taken
in the context of one data protection related complaint and nine personal data breaches that
occurred in ECHA and involving ECHA staff and/or stakeholders. Two of those personal data
breaches were communicated to the European Data Protection Supervisor (EDPS), as legally
required due to the risks to the rights and freedoms of the persons concerned. The first incident
concerned personal data being published unredacted on the biocides dissemination website,
while the second incident concerned the unauthorised disclosure of personal information due to
a software bug in a new version of ECHA CHEM. The latter incident has also been reported to
CERT-EU as an information security incident (more details on that incident are available under
“Security and business continuity” below). As required, these cases were recorded and reported,
and appropriate mitigating measures were agreed with process owners to prevent potential
occurrence in the future.
Security and business continuity
Regarding cybersecurity the new EU regulation was adopted in December 2023 laying out several
legal obligations. Implementation of the legal obligations has been ongoing in 2024 and will
continue into 2025 and beyond. An initial maturity assessment has been conducted and an initial
cybersecurity review and action plan prepared.
A risk assessment for the ICT environment has been conducted, with periodic follow up during
the 2024 quarterly reporting cycle with a focus on risks that are medium likelihood and impact
or higher.
Cybersecurity principles have been established and eight essential maturity assessments as
mandated by the cybersecurity regulation have been conducted. In addition, regarding data
protection various impact assessments were performed.
37
https://echa.europa.eu/documents/10162/10709201/final_mb_47_2022_annex1_anti-fraud-strategy_2023-
2026_en.pdf/c42eb6f4-1d61-5be9-83a4-3f4af5ee6b4e
75
Annual Report 2024
"Red Teaming" exercise conducted proposing several immediate, mid-term and long-term
security improvements. Public Cloud security assessments were conducted, evaluating the
security of ECHA’s cloud infrastructure and security risk.
Cybersecurity awareness campaign was continued with several Cybersecurity Awareness
trainings provided in 2024 as follows: “GDPR – The 7 Principles of Data Protection”, “GDPR –
Accountability and Compliance”, “What is Processing – Global Privacy”, “GDPR – What is Sensitive
Personal Data”.
In June 2024, ECHA experienced a data breach incident. A new version of the application ECHA
CHEM was deployed with a software bug, that allowed non-public information to be disseminated
to the public. The error was noticed early August, and as the first action the application was
shutdown. Investigation proved that the problem covered 680 registrations belonging to 291
legal entities i.e. companies, which were duly informed. The leaked dossiers were removed and
after thorough testing the public access was restored 25th August. The corrected new version of
the application was deployed successfully in late November. The case was also reported regularly
to CERT-EU, where the final report was sent in January 2025.
The ECHA CHEM incident is not classified as a “High Impact Security Incident” because it was
not caused by a cyberattack.
Conclusions of the assessment of the internal control systems
Component Conclusion
Governance
1.1 Purpose and The implementation of ECHA’s new strategy is on a good path, however more
vision efforts may be needed so that staff could link their work to the strategy.
Stakeholders have an overall good understanding of ECHA’s role, aims and
activities. The difference in the commitment of Directors and Heads of Units
to the new strategy may bear risks for its successful implementation.
1.2 Values and The principle is present and functioning. New values have been
behaviours communicated and upheld in 2024. More efforts are needed to exemplify
“innovation” and to further increase the transparency towards communicating
decisions and information to stakeholders. Awareness raising efforts on
dealing with sensitive topics need to remain high.
1.3 Management The Integrated Management System is functioning, and management and
responsibility staff are committed to its continual improvement. The overall management
perception of ECHA’s delegation and empowering staff has improved. The
quality assurance officers' satisfaction with the organisation of the Integrated
Management system has improved as well. Areas for attention include the
clarity in roles, responsibilities and accountabilities, minimising bureaucracy
and ensuring sustainability in the day-to-day operations.
1.4 People (Human ECHA has competent and highly qualified staff, and there is a management
Resources) commitment to enhance staff and competence development. Areas of
attention include the mapping of competence needs in particular with regards
to the new tasks, the length of the selection procedures, the effective
communication around the performance appraisal exercise and the adequate
resourcing of HR and horizontal services.
76
Annual Report 2024
1.5 Stakeholders ECHA has invested lots of efforts in improving its stakeholders’ engagement
and partners approach in 2024 thus addressing effectively all weaknesses as identified in
the Stakeholders’ audit. Some actions have already led to positive results in
terms of increased stakeholders’ commitment. Stakeholders are overall
satisfied with the support and services of ECHA, but request ECHA to put
further efforts into timely and approachable communication and more
visibility of how their input is taken into account. The roles and
responsibilities with regards to the oversight of the stakeholders’ repository
is an area for attention.
Strategy, planning and risk management
2.1 Goals planning In 2024, ECHA started the implementation of its new strategy which is
and resource considered to be on a good path and well communicated. Watch out areas
allocation are linked to the unclarity in the formulation of negative priorities, allocation
of resources in line with priorities, linking initiatives with strategic priorities,
and developing indicators with their respective consistent definitions to serve
the Management decision making.
2.2 Risk ECHA has put lots of efforts to strengthen its corporate risk management
management increasing the level of engagement of management and MB involvement.
ECHA’s overall low risk appetite may become a hurdle towards the process
improvements efforts of the Agency and implementing the value of the
innovation. Areas for attention include the clarity of roles and responsibilities
with regards to the consolidation and oversight of Units and Directorates
risks, the different practices around project risk management and the
inconsistency in performing cost-risk-benefit analysis and analysis of options
when starting new projects.
Operations and operational structure
3.1 Activity The activity and process management is a strength for ECHA and allows
management synergies. The optimisation of some regulatory activities, like Biocides, is
limited by the legal constraints within which they are required to operate.
Areas for attention include the potential risk of overdependence on few
contractors and the weaknesses in tracking the overall contractors’
performance.
3.2 Information and ECHA has been able to find some synergies and reuse some of its existing
data management platforms for new tasks. Stakeholders' satisfaction with ECHA’s website is
overall high. Roles and responsibilities between IT and operational
directorates need to be better defined. Areas for attention refer to the
timeliness and completeness of incident reporting, as well as the increased
risk of personal data breaches. The gap between the existing overall positive
IT indicators and the low perception of management on the efficiency,
security and reliability of IT systems is also a warning.
3.3 Change ECHA overall responds to changes flexibly whilst ensuring continuity of
management operations and changes foreseen with the Better Regulation may provide
further agility. At the moment, ECHA’s organisational structure may be
sometimes rigid and preventing innovation. Specific consideration should be
paid to the prerequisites (including the legislative ones) for maintaining a
flexible and agile management system in view of the changing stakeholders’
requirements and the onboarding of new tasks.
77
Annual Report 2024
Evaluation and improvement
4.1 Performance The adequacy of corporate metrics is currently being addressed, taking into
management account the balance between quantitative and qualitative indicators and the
data expectations of the different stakeholders groups. No critical gaps were
found from the analysis of non-conformities, complaints and exceptions
register. Attention is required in the area of data management with the need
to build more tailor – made and consistent reports that add more value to
Management decision – making.
4.2 Assessments, ECHA has adequate tools in their disposal to oversee the effectiveness,
audits, and adequacy, and suitability of the Agency’s Integrated Management System
evaluations through assessments, audits, and evaluations. There is a need to
systematically discuss learnings from mistakes, have less cumbersome follow
up audits and better integrate ex-post controls.
Statement of the manager in charge of risk management and internal control
I, the undersigned,
Shay O’MALLEY
Director of Resources
In my capacity as manager in charge of risk management and internal control, I declare that in
accordance with ECHA’s Internal Control Framework, I have reported my advice and
recommendations on the overall state of internal control in the Agency to the Executive Director.
I hereby certify that the information provided in the present Annual Report and in its annexes
is, to the best of my knowledge, accurate, reliable and complete.
Done in Helsinki, on 5 March 2025
signed
Shay O’MALLEY
Director of Resources
78
Annual Report 2024
Part IV. Management assurance
Review of the elements supporting assurance
The Authorising Officer performed an assessment of the effectiveness and efficiency of the
internal control system, acknowledging that the system, based on ECHA’s Integrated
Management Strategy and Framework, is functioning well. The assessment considered a broad
range of input and fed into the Management Review 2024, where senior management of the
Agency reflected on the strengths, weaknesses, risks and opportunities of the management
system. No significant weaknesses that may have a potential impact on the declaration of
assurance of the Authorising Officer were identified and reported in any of the relevant parts as
set out in the present report.
Reservations
Not applicable
79
Annual Report 2024
Part V. Declaration of assurance
Declaration of assurance by the Authorising Officer
I, the undersigned,
Dr Sharon McGuinness
Executive Director of the European Chemicals Agency
In my capacity as Authorising Officer,
Declare that the information contained in this report gives a true and fair view,
State that I have reasonable assurance that the resources assigned to the activities described
in this report have been used for their intended purpose and in accordance with the principles
of sound financial management, and that the control procedures put in place give the necessary
guarantees concerning the legality and regularity of the underlying transactions,
This reasonable assurance is based on my own judgement and on the information at my disposal,
such as the results of the self-assessment, ex post controls, the work of the Internal Audit
Capability, the recommendations of the Internal Audit Service and the lessons learnt from the
reports of the Court of Auditors 38 for years prior to the year of this declaration,
Confirm that I am not aware of anything not reported here which could harm the interests of the
Agency.
Done in Helsinki, on 21 March 2025
signed
Dr Sharon McGuinness
Executive Director
38
With regard to the implementation of EU legislation and the fee regulations under the Agency’s remit, this assurance
has to be limited to the field of competences of the Agency. Since ECHA’s mandate does not include controls or
inspections at national level, it cannot be confirmed that only registered or authorised substances and products, for
which a fee has been paid to the Agency, are circulating on the EU market.
80
Annual Report 2024
Annexes
81
Annual Report 2024
Annex I - Key indicators
82
Annual Report 2024
Annex II - Budget implementation reports and statistics on financial
management
Budget overview
The initially budgeted total payment appropriations for the Agency’s expenditure in 2024, as
concluded by the Management Board in December 2023, amounted to EUR 127.9 million,
including c. EUR 0.8 million for the separately budgeted other tasks (“Contribution Agreements
and SLAs” in the table below). During the year, two budget amendments were approved by the
Management Board, primarily for the following reasons: a) incorporating the agreed amounts to
be collected under the Contribution Agreements and SLAs (EUR 1.32 million increase), b)
excluding the EU contribution (and EFTA contribution) relating to the water protection legislation,
due to delay in its adoption (EUR 1.65 million decrease), c) incorporating the additional EU
contribution reinforcement, concluded centrally for all EU Agencies following the adjustment in
salaries (EUR 0.98 million increase), and d) adjusting the fee income and bank interest income
(EUR 0.15 million net increase). The final total expenditure, concluded in the 2nd amending budget
in November 2024, amounted to EUR 128.7 million, including EUR 2.1 million for the separately
budgeted Contribution Agreements and SLAs.
Revenue Initial voted budget Amending budgets Final voted budget
Total revenue 127 918 559 794 107 128 712 666
Expenditure Initial voted budget Amending budgets Final voted budget
Commitment appropriations 127 955 559 530 848 128 486 407
Payment appropriations 127 918 559 794 107 128 712 666
Revenue
The budget funding of ECHA in 2024 consisted of the following (amounts in EUR):
Initial voted Final voted Entitlements Revenue
Amendments
Description Budget Budget established received
2024
2024 2024 2024 2024
Fees and charges from Registrations & Updates 24 751 025 1 159 645 25 910 670 26 201 769 26 201 769
Fees and charges from Authorisations 2 970 000 (1 195 000) 1 775 000 1 707 126 1 707 126
Fees SME Administration 700 000 - 700 000 617 358 617 358
Fees and charges from CLP 90 500 - 90 500 66 500 66 500
Fees and charges from appeals - 12 556 12 556 29 298 29 298
Total REACH Fees & Charges Income 28 511 525 (22 799) 28 488 726 28 622 051 28 622 051
Fees relating to Biocidal Active Substances 712 975 (250 000) 462 975 570 500 570 500
Fees for Union Authorisation of Biocidal products 2 346 851 220 000 2 566 851 2 789 000 2 789 000
Miscellaneous fees 2 566 000 30 000 2 596 000 2 322 300 2 322 300
Fees and charges from appeals 0 2 500 2 500 5 000 5 000
Total BPR Fee & Charges Income 5 625 826 2 500 5 628 326 5 686 800 5 686 800
REACH EU Contribution 73 971 000 835 000 74 806 000 74 806 000 74 806 000
BPR EU Contribution 7 745 000 86 585 7 831 585 7 831 585 7 831 585
ENV EU Contribution 6 931 688 (1 540 460) 5 391 228 5 391 228 5 391 228
EFTA Contribution – REACH 2 499 040 - 2 499 040 2 499 040 2 499 040
EFTA Contribution – BPR 227 286 - 227 286 227 287 227 287
Confederation of Switzerland Contribution – BPR 346 201 - 346 201 346 201 346 201
EFTA Contribution – ENV 246 281 (55 148) 191 133 191 133 191 133
Total EU and other Contributions 91 966 496 (674 023) 91 292 473 91 292 475 91 292 475
Contribution Agreement EUON - - - 619 000 619 000
Contribution Agreement EUCLEF - - - 1 053 400 1 053 400
Contribution Agreement OELs - 975 000 975 000 975 000 975 000
Contribution Agreement SCBTH - - - 520 000 520 000
SLA with EFSA 784 712 345 000 1 129 712 1 129 712 1 129 712
83
Annual Report 2024
Total Contribution Agreements and SLAs 784 712 1 320 000 2 104 712 4 297 112 4 297 112
Bank Interest Income 1 030 000 168 429 1 198 429 1 440 219 1 440 219
Other income – miscellaneous - - - 47 760 48 781
Total Administrative Operations Income 1 030 000 168 429 1 198 429 1 487 979 1 489 000
Total 127 918 559 794 107 128 712 666 131 386 416 131 387 437
REACH/CLP Revenue
A) REACH/CLP Fees and Charges
ECHA is financed through fees paid by industry and by an EU balancing contribution, in accordance
with the REACH Regulation (No 1907/2006). The fees and charges collected by ECHA are
determined by the REACH Fee Regulation and by the decisions of the Management Board.
Due to the one-off nature of REACH fees and their dependence on strategic decisions of the
chemical industry players, there is high uncertainty as to their amount and timing.
The budgetary revenue from REACH fees and charges in 2024, in terms of cash received,
amounted to EUR 28.59 million (EUR 30.90 million in 2023). In addition, EUR 0.03 million (EUR
0.03 million in 2023) was recorded in relation to REACH appeal fees 39 giving a total of fees and
charges of EUR 28.62 million (EUR 30.93 million in 2023).
Broken down by fee category, ECHA collected a total of EUR 26.20 million from REACH
Registrations and Updates fees (EUR 26.68 million in 2023), EUR 1.71 million from Applications
for Authorisation (EUR 3.30 million in 2023) and EUR 0.07 million from CLP fees (EUR 0.10 million
in 2023). The additional registration fee income that was generated through the SME company
size verification process (which is included in the REACH registrations and updates income)
amounted to EUR 0.36 million in 2024 (EUR 0.52 million in 2023). On top of the additional
registration fees, the Agency generated EUR 0.62 million in administrative charges (EUR 0.82
million in 2023) levied on companies who were deemed non-eligible for the granted SME fee
rebates.
B) REACH/CLP Contributions from the General Budget of the EU
During 2024, the Agency received an EU balancing contribution for REACH/CLP of EUR 74.81
million (EUR 66.81 million in 2023) and a European Free Trade Association (EFTA) contribution of
EUR 2.50 million (EUR 2.00 million in 2023).
BPR Revenue
A) BPR Fees and Charges
In accordance with the Biocidal Products Regulation (BPR, No 528/2012), ECHA is financed
through fees paid by industry and a balancing EU contribution. The biocide fees and charges
collected by ECHA are determined by the Biocidal Products Regulation and the BPR Fees and
Charges Regulation. The budgetary revenue from biocidal product fees and charges for 2024, in
terms of cash received, amounted to EUR 5.69 million (EUR 2.79 million in 2023). The significant
increase in the collected BPR fee income relates primarily to the significantly increased number
of Union Authorisation applications, for single products and for product family, received in 2024
compared to 2023 (25 applications in 2024 vs. 6 applications in 2023).
39
Income from appeal fees is recognised by ECHA only when a case has been decided and the Board of Appeal rules
that the fee should not be refunded to the applicant.
84
Annual Report 2024
B) BPR Contributions from the General Budget of the EU
During 2024, the Agency received an EU balancing contribution of EUR 7.83 million (EUR 9.56
million in 2023) and an EFTA contribution of EUR 0.23 million (EUR 0.19 million in 2023). In
addition, the Agency received a contribution from the Confederation of Switzerland of EUR 0.35
million (EUR 0.38 million in 2023).
Environmental Policy Revenue
In accordance with the Prior Informed Consent (PIC) Regulation (EU) No 649/2012, Persistent
Organic Pollutants (POPs) Regulation (EU)2019/2021, Waste Framework Directive (SCIP) (EU)
2018/851 amending Directive 2008/98/EC, the revised Drinking Water Directive (DWD) Directive
(EU) 2020/2184, the 8th Environmental Action Programme (8th EAP), the Batteries Regulation and
the Industrial Emissions Directive (IED), ECHA is fully financed through an EU contribution for
these activities. In 2024, the EU contribution amounted to EUR 1.31 million for PIC (EUR 1.22
million in 2023), EUR 0.31 million for POPs (EUR 0.29 million in 2023), EUR 1.09 million for SCIP
(EUR 1.34 million in 2023), EUR 1.24 million for DWD (EUR 1.72 million in 2023), EUR 0.34 million
for 8th EAP (EUR 0.33 million in 2023), EUR 0.48 million for the Batteries Regulation (new task in
2024) and EUR 0.62 million for IED (new task in 2024), totalling EUR 5.39 million (EUR 4.91
million in 2023). Furthermore, in 2024, the Agency received an EFTA contribution of EUR 0.19
million (EUR 0.14 million in 2023) in total for the above tasks.
Contribution Agreements and Service Level Agreements
The Agency has signed contribution agreements with the European Commission to implement the
European Union Observatory for Nanomaterials (EUON) and the European Union Chemicals
Legislation Finder (EUCLEF). ECHA has also signed a Service Level Agreement with the European
Commission to provide opinions for occupational exposure limits (OELs). Additionally, the Agency
has signed a Service Level Agreement with the European Food Safety Authority (EFSA) for
developing and implementing IUCLID software solutions for plant protection products. Finally, in
2024, the Agency signed a contribution agreement with the European Commission for the
implementation of tasks under the Serious Cross-Border Threats to Health (SCBTH), to carry out
and deliver public health risk assessments on chemical incidents. In 2024, ECHA received an
amount of EUR 4.30 million in aggregate for implementing these tasks. It is to be noted that the
Agency has also signed a Service Level Agreement with the European Commission for work with
respect to the Instrument for Pre-Accession Assistance (IPA), for which no additional funding was
collected during 2024.
Other miscellaneous income
The table below shows the other miscellaneous income received by the Agency in 2024 and 2023
(amounts in EUR).
Revenue Revenue
Description received received
2024 2023
Bank Interest income 1 440 219 930 573
Legal recoveries - 50 791
Late interest income 3 425 6 176
Recoveries from other EU agencies 43 092 57 456
Other recoveries 2 264 14 052
Other income - miscellaneous 48 781 128 475
Total Administrative Operations Income 1 489 000 1 059 048
85
Annual Report 2024
Fee Invoicing
In accordance with Article 71 of the Agency’s Financial Regulation, the number of debit notes
issued, and their global amount shall be provided in the Agency’s report on budgetary and
financial management. In addition, where fees and charges are entirely determined by legislation
or decisions of the Management Board, the Authorising Officer may abstain from issuing recovery
orders and directly draw up debit notes after having established the amount receivable. Where
the Agency uses a separate invoicing system, the Accounting Officer shall regularly, and at least
on a monthly basis, enter the accumulated sum of fees and charges received into the accounts.
The Agency uses a separate invoicing and debtors’ system for daily transactions related to fee
income, namely the REACHIT (for REACH/CLP fees and charges) and REACH-NG (for Biocidal
Products fees and charges) invoicing modules. The invoices raised and the payments received are
recorded in the central accounting system on a monthly basis.
A) REACH Fees and Charges
The total net invoiced by the Agency in 2024 amounted to EUR 28.46 million (EUR 31.01 million
in 2023 and EUR 33.02 million in 2022). The table below depicts the breakdown of the net invoiced
REACH fees during the years 2022-2024.
REACH 2024 2023 2022
No of No of No of
Description EUR EUR EUR
Invoices Invoices Invoices
Invoices issued 5 670 30 915 187 5 743 33 510 775 6 579 35 011 416
Credit Notes 150 (1 998 717) 131 (1 790 613) 494 (1 628 744)
Unpaid 76 (455 495) 136 (710 941) 111 (364 332)
Considered paid 14 (259) 14 (259) 17 (842)
Net Invoiced 28 460 716 31 008 962 33 017 498
Write offs - - 5 (87 682) 13 (238 488)
On 31 December 2024, the amount to be recovered for REACH fees and charges, before any year-
end accounting adjustments, stood at EUR 1.89 million relating to 274 open invoices (on 31
December 2023, the amount to be recovered for REACH fees and charges, before any year end
accounting adjustment, stood at EUR 2.05 million relating to 266 open invoices).
B) Biocidal Products Fees and Charges
The total net invoiced by the Agency in 2024 amounted to EUR 5.98 million (EUR 2.88 million in
2023 and EUR 6.80 million in 2022). The table below depicts the breakdown of the net invoiced
BPR fees during the year.
BPR 2024 2023 2022
No of No of No of
Description EUR EUR EUR
Invoices Invoices Invoices
Invoices issued 1 098 6 599 900 608 3 618 500 1 201 8 232 100
Credit Notes 56 (603 600) 51 (589 500) 103 (1 347 000)
Unpaid 15 (17 000) 14 (149 500) 37 (81 400)
Considered paid - - - - 3 (95)
Net Invoiced 5 979 500 2 879 500 6 803 605
On 31 December 2024, the amount to be recovered for Biocidal product fees and charges before
any year end accounting adjustments, stood at EUR 0.48 million relating to 72 open invoices (on
86
Annual Report 2024
31 December 2023, the amount to be recovered for BPR fees and charges, before any year end
accounting adjustment, stood at EUR 0.18 million relating to 24 open invoices).
Expenditure
ECHA’s expenditure budget consists of commitment appropriations (CA) and payment
appropriations (PA). The initial CAs totalled EUR 127.2 million and the initial PAs totalled EUR
127.1 million, while the figure concluded in the final budget is EUR 126.4 million for CAs and EUR
126.6 million for PAs. These commitment and payment appropriations consist of C1 funds only,
i.e. excluding the R0 funds ("Contribution Agreements and SLAs") of EUR 0.8 million from initial
Budget and EUR 2.1 million from final budget.
Budget expenditure includes payments made during the year and the carry-over of budgetary
appropriations. Summary of the execution of appropriations per title and a more detailed
breakdown is provided in the ‘Statistics on Financial Management and Budget (Expenditure)’
section below.
Changes and implementation of the commitment appropriations for 2024 (C1)
The initially adopted budget for the Agency in 2024 was EUR 127.2 million and the overall net
decrease during the year, including 26 transfers and two amending budgets, was c. EUR 0.8
million, to arrive at EUR 126.4 million as the final budget.
The final executed amount totalled EUR 125.8 million corresponding to an execution rate of 99.5
% for the appropriations.
Carry over of appropriations to 2025
The commitment and payment appropriations carried over to 2025 totals EUR 15.9 million,
corresponding to 12.6 % of the committed amount.
The carry-over of staff related expenditure, budgeted in Title 1, was insignificant and mainly
relates to the commitments for training and interim services.
In Title 2, covering the Agency’s infrastructure, the carry-over totalled EUR 3.4 million, stemming
mainly from commitments related to ECHA’s IT services.
The operational expenditure required to implement the Work Programme for the different
regulations is budgeted in Title 3 for REACH and CLP, in Title 4 for Biocides, and in Title 5 for the
Environmental Policy (PIC, POPs, Waste Framework Directive (SCIP), Drinking Water Directive,
the 8th Environmental Action Programme, Batteries Regulation and Industrial Emissions
Directive). The carry-over in operational titles totalled EUR 12.2 million and is mostly related to
IT development projects.
The relatively high level of carry-overs stems from the contracting cycle caused largely by the
uncertainty in the fee income. In the past years, ECHA has had to wait late in the year before
signing the contracts to make sure sufficient funds will be available, and at the same time, has
had to sometimes frontload certain projects when the income has exceeded the estimates. This
had led to a situation where, during the first part of the year, the focus has been on implementing
the projects carried over and new projects are only commenced during the second half and
sometimes even during the last quarter of the year.
87
Annual Report 2024
Implementation of the appropriations carried over from 2023 (C8)
The amount carried over from 2023 totalled EUR 14.4 million and the finally executed amount
was EUR 14.3 million, corresponding to 99.4 %. The cancelled 0.6 % relates mostly to meetings
that took place at the end of 2023, where the actual costs were lower than anticipated, and lower
than anticipated costs for legal services related to debt collection of administrative charges in
Title 3.
Late interest payments
During the year 2024, ECHA did not pay late interest for commercial invoices.
Procurement procedures
During 2024 budget implementation:
• ECHA signed a total 368 contracts and purchase orders 40.
• 282 were specific contracts and orders under existing framework contracts (FWC) and 86
were contracts resulting from new tendering procedures.
• ECHA concluded 9 new FWCs:
o for management standard certification services,
o for methodological developments and data generation for the assessment and
building of sets of nanoforms (NAMs),
o for scientific and technical support work related to hazard assessment and
identification (4 lots),
o for support on the POP dossier for D4, D5 and D6,
o for support to risk management work under REACH and other legislations
(restriction support),
o for interim services,
o for canteen and catering services,
o for travel services,
o for office supplies.
ECHA also signed multiannual contracts for banking services and the info desk and established a
Dynamic Purchasing System (DPS) for IT services.
ECHA joined 8 inter-institutional FWCs:
• for thematic communication services (COM),
• for impact assessment, evaluation, studies in communications (COM),
• for digital communication and social media (COM),
• for data protection advice, consultancy and related services II (EBA),
• for engagement and community management services (EFSA),
• for learning and development services for staff on general skills, resilience & wellbeing
(EPSO),
• for EU IPR management and annuities & renewal services (JRC)
• for legal advice services in respect of EU intellectual property rights (JRC).
A total of 20 contracts were signed following negotiated procedures without prior publication,
based on the relevant rules of the Financial Regulation (Annex 1–11.1):
• 13 for legal services
• 7 (for technical reasons) for specific scientific expertise, for subscriptions to scientific
40
This number also includes amendments with budgetary commitment.
88
Annual Report 2024
database and professional journals, as well as for specialised software.
In 2024, the performance of the suppliers of the Agency was satisfactory overall and in accordance
with the terms of the contracts, with few exceptions, which were successfully addressed by ECHA.
Preliminary market consultation in the form of questionnaires to be filled in by potential tenderers
continues being an established practice in ECHA, before launching procurement.
Green Public Procurement (GPP) remains a priority and an integral part of the Agency’s
management system and was extended beyond technical equipment also to apply to tenderers
providing human labour-based services/expert services (DPS for IT services). Furthermore, ECHA
used demonstration of social responsibility as part of the financial award criterion in the new FWC
for interim services.
The introduction of Qualified Electronic Signature for all Authorising Officers directly in EasySign
workflow tool has brought significant efficiencies to signing contracts. Through the NAPO network
the procurement team joined an expert group to analyse possibilities, limitations and legality of
using artificial intelligence in procurement procedures.
ECHA continued relying on IT tools (e.g., Cloudia for the DPS, PPMT) in its procurement and
contract processes. The annual list of contractors is published by ECHA by 30 June of each year
for the previous year on ECHA’s website 41.
Acts of delegation and sub delegation
For the purposes of the budget implementation, and in line with Article 41(1) of ECHA’s Financial
Regulation, the Executive Director as the Authorising Officer of the Agency has delegated financial
powers to the directors for the budget lines which they are responsible for, in line with their
activities.
In accordance with Article 41(2), the directors have further sub-delegated financial powers to the
heads of unit of their directorates.
For efficiency reasons, the Executive Director has also delegated financial powers to authorise
payments below EUR 8 000 to staff in the Finance Unit.
41
https://echa.europa.eu/view-article/-/journal_content/title/annual-list-of-awarded-contracts
89
Annual Report 2024
Statistics on Financial Management and Budget (Expenditure)
Budget 2024: Breakdown and changes in commitment appropriations and implementation of the appropriations for the
current year (C1) per Title* (EUR)
Final Final
Executed Executed Carried
Transfers / Available % Available % Carried over
Budget 2024 Commitment Payment over Cancelled
Title Description amendments Commitment Committed Payment Paid RAL (C8)
(1) Amount Amount % (3)-(4)
(2) Appropriations (4)/(3) Appropriations (6)/(5) (7)
(4) (6) (7)/(4)
(3) (5)
A-1 STAFF 83 470 319 -161 235 83 309 084 83 077 124 99.7% 83 309 084 82 825 344 99.4% 251 781 0.3% 231 960
BUILDING. EQUIPMENT AND MISCELL
A-2 19 375 816 2 748 784 22 124 600 22 105 259 99.9% 22 124 600 18 720 102 84.6% 3 385 157 15.3% 19 341
OPER EXPEND
OPERATIONAL EXPENDITURE -
B0-3 18 936 545 -2 437 833 16 498 712 16 217 153 98.3% 16 724 971 7 240 868 43.3% 9 178 319 56.6% 281 559
REACH/CLP
OPERATIONAL EXPENDITURE -
B0-4 2 609 929 -124 718 2 485 211 2 441 849 98.3% 2 485 211 884 206 35.6% 1 557 644 63.8% 43 362
BIOCIDES
OPERATIONAL EXPENDITURE -
B0-5 2 778 238 -814 150 1 964 088 1 958 107 99.7% 1 964 088 475 451 24.2% 1 482 657 75.7% 5 981
ENVIRONMENTAL POLICY
127 170 847 -789 152 126 381 695 125 799 492 99.5% 126 607 954 110 145 970 87.0% 15 855 557 12.6% 582 203
*Note: As ECHA operates with both differentiated (multi-annual) and non-differentiated (annual) budget lines, the funds reserved for commitments
(commitment appropriations) do not equal the funds reserved for payments (payment appropriations). The results for the administrative titles 1 and 2 are
combined for all three regulations.
90
Annual Report 2024
Budget 2024: Breakdown and changes in commitment appropriations and implementation of the appropriations for the current
year (C1) per Regulation and Title (EUR)
REACH/CLP
Final Final
Executed Executed Carried Carried
Transfers / Available % Available %
Budget 2024 Commitment Payment over over Cancelled
Title Description amendments Commitment Committed Payment Paid
(1) Amount Amount RAL (C8) % (3)-(4)
(2) Appropriations (4)/(3) Appropriations (6)/(5)
(4) (6) (7) (7)/(4)
(3) (5)
A-1 STAFF 70 761 345 1 081 796 71 497 541 71 315 955 99.7% 71 497 541 71 099 811 99.4% 216 144 0.3% 181 586
BUILDING. EQUIPMENT AND
A-2 16 120 675 1 974 979 18 441 254 18 425 175 99.9% 18 441 254 15 575 125 84.5% 2 850 051 15.5% 16 079
MISCELL. OPER EXPEND
OPERATIONAL EXPENDITURE
B0-3 18 936 545 -2 437 833 16 498 712 16 217 153 98.3% 16 724 971 7 240 868 43.3% 9 178 319 56.6% 281 559
- REACH/CLP
105 818 565 618 942 106 437 507 105 958 283 99.5% 106 663 766 93 915 804 88.0% 12 244 513 11.6% 479 224
BIOCIDES
Final Final
Executed Executed Carried Carried
Transfers / Available % Available %
Budget 2024 Commitment Payment over over Cancelled
Title Description amendments Commitment Committed Payment Paid
(1) Amount Amount RAL (C8) % (3)-(4)
(2) Appropriations (4)/(3) Appropriations (6)/(5)
(4) (6) (7) (7)/(4)
(3) (5)
A-1 STAFF 9 255 539 -21 813 9 213 776 9 204 749 99.9% 9 213 776 9 181 950 99.7% 22 799 0.2% 9 027
BUILDING. EQUIPMENT AND
A-2 2 208 845 270 616 2 499 411 2 497 199 99.9% 2 499 411 2 134 092 85.4% 363 108 14.5% 2 212
MISCELL. OPER EXPEND
OPERATIONAL EXPENDITURE
B0-4 2 609 929 -124 718 2 485 211 2 441 849 98.3% 2 485 211 884 206 35.6% 1 557 644 63.8% 43 362
- BIOCIDES
14 074 313 124 085 14 198 398 14 143 797 99.6% 14 198 398 12 200 247 85.9% 1 943 550 13.7% 54 601
ENVIRONMENTAL POLICY
Final Final
Executed Executed Carried Carried
Transfers / Available % Available %
Budget 2024 Commitment Payment over over Cancelled
Title Description amendments Commitment Committed Payment Paid
(1) Amount Amount RAL (C8) % (3)-(4)
(2) Appropriations (4)/(3) Appropriations (6)/(5)
(4) (6) (7) (7)/(4)
(3) (5)
A-1 STAFF 3 453 435 -846 218 2 597 767 2 556 421 98.4% 2 597 767 2 543 582 97.9% 12 838 0.5% 41 346
BUILDING. EQUIPMENT AND
A-2 1 046 296 128 189 1 183 935 1 182 884 99.9% 1 183 935 1 010 885 85.4% 171 998 14.5% 1 051
MISCELL. OPER EXPEND
OPERATIONAL EXPENDITURE
B0-5 2 778 238 -814 150 1 964 088 1 958 107 99.7% 1 964 088 475 451 24.2% 1 482 657 75.7% 5 981
- ENVIRONMENTAL POLICY
7 277 969 -1 532 179 5 745 790 5 697 412 99.2% 5 745 790 4 029 918 70.1% 1 667 493 29.3% 48 378
91
Annual Report 2024
Budget 2024: Implementation of differentiated appropriations (EUR)
Available Available
Commitments Payments
Budget line commitment % payment %
made made
appropriations appropriations
B3-111 Substance evaluation and Rapporteurs (Multiannual) 618 894 617 815 99.83% 838 152 814 001 97.12%
Cooperation with international organisations for IT
B3-801 502 300 500 015 99.55% 509 301 505 864 99.33%
programs
Total 1 121 194 1 117 830 c.100% 1 347 453 1 319 865 97.95%
Out of the total available commitment appropriations of EUR 1 562 595, the amount of EUR 891 719 is stemming from commitments made in
earlier financial years. The available commitment appropriations for 2024 totalled EUR 1 121 194 out of which EUR 1 117 830 (c.100%) were
committed.
92
Annual Report 2024
Budget 2024: Implementation of assigned revenue (C4, C5, R0) (EUR)
Carried over Carried over
Commitments Commitments Payments Payments
Title Description FS Com % Pay% commitment payment
Appropriations Established Appropriations Executed
appropriations appropriations
A-1 STAFF C4 43 602 0 0.0% 43 602 0 0.0% 43 602 43 602
A-2 BUILDING. EQUIPMENT AND MISCELL. OPER EXPEND C4 3 425 0 0.0% 3 425 0 0.0% 3 425 3 425
B0-3 OPERATIONAL EXPENDITURE - REACH/CLP C4 1 243 0 0.0% 1 243 0 0.0% 1 243 1 243
C4 48 270 0 0.0% 48 270 0 0.0% 48 270 48 270
Carried over Carried over
Commitments Commitments Payments Payments
Title Description FS Com % Pay% commitment payment
Appropriations Established Appropriations Executed
appropriations appropriations
A-1 STAFF C5 20 345 20 345 100.0% 20 345 20 345 100.0% 0 0
A-2 BUILDING. EQUIPMENT AND MISCELL. OPER EXPEND C5 6 176 6 176 100.0% 6 176 6 176 100.0% 0 0
B0-3 OPERATIONAL EXPENDITURE - REACH/CLP C5 29 477 28 009 95.0% 29 477 25 791 87.5% 0 2 219
B0-4 OPERATIONAL EXPENDITURE - BIOCIDES C5 153 153 100.0% 153 153 100.0% 0 0
C5 56 150 54 682 97.4% 56 150 52 464 93.4% 0 2 219
Carried over Carried over
Commitments Commitments Payments Payments
BL Description FS Com % Pay% commitment payment
Appropriations Established Appropriations Executed
appropriations appropriations
B6-000 IPA programme R0 472 488 185 892 39.3% 472 488 185 732 39.3% 286 596 286 756
B6-010 EUON R0 1 513 432 844 452 55.8% 1 513 432 578 167 38.2% 668 981 935 266
B6-011 EUCLEF R0 3 280 552 1 607 166 49.0% 3 280 552 981 274 29.9% 1 673 385 2 299 277
B6-020 Occupational exposure limits R0 1 560 820 950 210 60.9% 1 560 820 818 365 52.4% 610 610 742 455
B6-021 Further development of IUCLID (w/ third parties) R0 1 898 451 1 600 758 84.3% 1 898 451 1 198 843 63.1% 297 693 699 608
B6-022 Support to cross-border threats to health (SCBTH) R0 520 000 0.0% 520 000 0.0% 520 000 520 000
R0 9 245 744 5 188 479 56.1% 9 245 744 3 762 381 40.7% 4 057 265 5 483 362
93
Annual Report 2024
Budget 2024: Implementation of the appropriations carried forward from previous year (C8) Per Title (EUR)
Carried Forward from
Title Description Paid Cancelled % Cancelled
2023
A-1 STAFF 296 082 290 902 5 180 1.7%
A-2 BUILDING. EQUIPMENT AND MISCELL. OPER EXPEND 2 606 583 2 595 821 10 762 0.4%
B0-3 OPERATIONAL EXPENDITURE - REACH/CLP 8 610 244 8 556 134 54 110 0.6%
B0-4 OPERATIONAL EXPENDITURE - BIOCIDES 1 269 456 1 256 830 12 626 1.0%
B0-5 OPERATIONAL EXPENDITURE - ENVIRONMENTAL POLICY 1 588 521 1 586 926 1 595 0.1%
14 370 886 14 286 613 84 273 0.6%
94
Annual Report 2024
Annex III – Organisational chart
95
Annual Report 2024
Annex IV - Establishment plan and additional information on human resources
management
Last establishment plan adopted
Establishment plan in voted EU Budget
Posts filled 31 December 2024 42
2024
Category
and grade
TA TA
REACH/ REACH/
Biocides ENV TOTAL Biocides ENV TOTAL
CLP CLP
AD 15 0 0
AD 14 6 6 3 3
AD 13 13 1 14 4 4
AD 12 12 2 14 11 1 12
AD 11 30 1 31 17 1 18
AD 10 41 5 46 46 6 52
AD 9 60 10 1 71 41 7 1 49
AD 8 52 9 61 60 7 67
AD 7 53 9 6 68 48 4 1 53
AD 6 27 5 10 42 41 9 4 54
AD 5 16 1 17 32 6 4 42
Total AD 310 43 17 370 303 41 10 354
AST 11 0 0
AST 10 0 0
AST 9 3 3 0
AST 8 8 8 6 6
AST 7 10 1 2 13 12 12
AST 6 18 1 19 18 1 1 20
AST 5 26 3 2 31 17 2 19
AST 4 16 3 2 21 10 4 3 17
AST 3 10 1 11 13 2 15
AST 2 3 3 14 2 16
AST 1 0 0
Total AST 94 9 6 109 90 9 6 105
AST/SC 6 0 0
AST/SC 5 0 0
AST/SC 4 0 0
AST/SC 3 0 0
AST/SC 2 0 0
AST/SC 1 0 0
TOTAL
404 52 11 467 393 50 16 459
AD+AST
CA CA
42
Under recruitment (included in figures): REACH: 2 TAs
96
Annual Report 2024
estimated need of FTEs 2024 posts filled 31 December 2024 43
REACH/ Other REACH/ Other
Biocides ENV TOTAL Biocides ENV TOTAL
CLP tasks CLP tasks
CA FG IV 27 7 12 13 59 18 6 5 9 38
CA FG III 53 6 3 1 63 57 6 6 4 73
CA FG II 17 2 0.5 19.5 19 2 21
CA FG I 0 0
TOTAL 97 15 15 14.5 141.5 94 14 11 13 132
Percentage of posts filled on 31 December 2024
REACH/ CLP Biocides ENV
TA posts 97.28% 96.15% 69.57% 44
CA posts 96.91% 93.33% 73.33%
Geographical and gender balance (as per 31 December 2024) 45
TA CA OVERALL
Nationality %
Male Female Total Male Female Total Sum
1 AT Austrian 3 4 7 0 0 0 7 1.2%
2 BE Belgian 11 10 21 2 1 3 24 4.1%
3 BG Bulgarian 1 9 10 3 4 7 17 2.9%
4 CY Cypriot 0 0 0 1 0 1 1 0.2%
5 CZ Czech 0 3 3 1 0 1 4 0.7%
6 DE German 17 7 24 0 0 0 24 4.1%
7 DK Danish 1 1 2 0 0 0 2 0.3%
8 EE Estonian 0 6 6 1 0 1 7 1.2%
9 ES Spanish 18 12 30 5 4 9 39 6.6%
10 FI Finnish 57 87 144 15 31 46 190 32.3%
11 FR French 20 15 35 3 7 10 45 7.7%
12 GR Greek 15 7 22 4 6 10 32 5.4%
13 HR Croatian 0 0 0 0 2 2 2 0.3%
14 HU Hungarian 2 7 9 0 4 4 13 2.2%
15 IE Irish 10 7 17 0 1 1 18 3.1%
16 IS Iceland 0 0 0 0 0 0 0 0.0%
17 IT Italian 23 18 41 6 5 11 52 8.8%
18 LI Liechtenstein 1 0 1 0 0 0 1 0.2%
19 LT Lithuanian 1 6 7 0 0 0 7 1.2%
20 LU Luxembourger 0 0 0 0 0 0 0 0.0%
21 LV Latvian 2 5 7 0 1 1 8 1.4%
22 MT Maltese 0 3 3 0 0 0 3 0.5%
23 NL Dutch 9 5 14 3 1 4 18 3.1%
43
Under recruitment (included in figures): BIOCIDES: 1 CA.
44
The posts related to the Water directives (3 TAs and 4 CAs) were expected to come to ECHA during 2024 and were
foreseen in the Authorised budget. However, the posts were not received in 2024. This negatively affects the 'posts
filled' ratio.
45
Data in the table includes statutory staff in place on the indicated date. Posts under recruitment are not included.
97
Annual Report 2024
24 NO Norwegian 0 1 1 0 0 0 1 0.2%
25 PL Polish 8 10 18 1 2 3 21 3.6%
26 PT Portuguese 6 7 13 0 2 2 15 2.6%
27 RO Romanian 3 5 8 2 8 10 18 3.1%
28 SE Swedish 3 2 5 1 0 1 6 1.0%
29 SI Slovenian 3 3 6 1 1 2 8 1.4%
30 SK Slovakian 1 2 3 0 2 2 5 0.9%
31 Other Other 0 0 0 0 0 0 0 0.0%
TOTAL 215 242 457 49 82 131 588 100.0%
Middle and senior management – gender and nationality overview 46
NATIONALITY MALE FEMALE TOTAL %
BE Belgian 2 0 2 5.9%
DE German 2 0 2 5.9%
ES Spanish 2 1 3 8.8%
FI Finnish 3 4 7 20.6%
FR French 3 1 4 11.8%
GR Greek 1 0 1 2.9%
IE Irish 4 2 6 17.6%
IT Italian 2 0 2 5.9%
MT Maltese 0 1 1 2.9%
NL Dutch 2 0 2 5.9%
PT Portuguese 1 0 1 2.9%
RO Romanian 0 1 1 2.9%
SE Swedish 1 0 1 2.9%
SI Slovenian 1 0 1 2.9%
Total OVERALL 24 10 34 100%
Results of the screening / benchmarking exercise
Function
Indication whether the
group, grade
Type of function is dedicated to
of
contract recruitment administrative support or
Key functions
(official, (or bottom of operations subject to
TA or CA) grade bracket definitions used in
if published screening methodology
with such
Core functions
TA – 5+5
Executive Director AD 14 Management-Operations
years
TA – 5+5
years +
Deputy Executive Director indefinite AD 14 Management-Operations
Director (Head of Directorate)
TA – 5+5 AD 12 Management-Operations
(Level 2)
46
Data in the table includes statutory staff in place on the indicated date. Posts under recruitment are not included.
98
Annual Report 2024
Function
Indication whether the
group, grade
Type of function is dedicated to
of
contract recruitment administrative support or
Key functions
(official, (or bottom of operations subject to
TA or CA) grade bracket definitions used in
if published screening methodology
with such
years +
indefinite
TA – 5+5
Head of Unit years + Operations/Administration
(Level 3) indefinite AD 9
TA – 5+5 AD 5 and
years + higher Operations/Administration
Administrator indefinite depending on
profile
Administration
TA – 5+5
years +
Head of Administration (Head of Directorate) indefinite Management-
(Level 2) AD 12
Administration
TA – 5+5
Head of Human Resources years +
(Level 3) indefinite AD 9 Administration
TA – 5+5
Head of Finance years +
(Level 3) indefinite AD 9 Administration
TA – 5+5
Head of
Communications years +
indefinite AD 9 Administration
(Level 3)
TA – 5+5
Head of IT years +
(Level 3) indefinite AD 9 Administration
TA - 5+5 AST 1 and
years + higher
Assistant indefinite depending on Operations/Administration
profile, up to
AST 4
Special functions
TA - 5+5
ECHA Committee Chair years + AD 10 Operations
indefinite
99
Annual Report 2024
Function
Indication whether the
group, grade
Type of function is dedicated to
of
contract recruitment administrative support or
Key functions
(official, (or bottom of operations subject to
TA or CA) grade bracket definitions used in
if published screening methodology
with such
TA – 5+5
Board of Appeal Chair AD 12 Operations
years
TA - 5+5
years +
Data Protection Officer indefinite AD 6 Administration
TA - 5+5
years +
Accounting Officer indefinite AD 8 Administration
TA - 5+5
years +
Internal Auditor indefinite AD 10 Administration
Benchmarking against previous results
ECHA undertook the benchmarking (job screening) exercise in 2024, in accordance with the
Commission’s requirements. The 2024 results indicate a decrease of 2.6% in the percentage of
administrative support and coordination staff, an increase of 2.1% in the percentage of the
operational staff and an increase of 0.5% in the percentage of neutral staff in comparison to
2023.
Job Type (sub) category 2023 (numbers in %) 2024 (numbers in %)
Administrative support and Coordination 14.8 12.2
Administrative Support 12.1 9.6
Coordination 2.8 2.6
Operational 81.6 83.7
Top level Operational Coordination 2.5 2.4
Programme management and
56.1 61.9
Implementation
Evaluation & Impact assessment 3.2 2.3
General operational 19.8 17.1
Neutral 3.6 4.1
Finance/ Control 3.6 4.1
Linguistics 0.0 0.0
100
Annual Report 2024
Annex V – Human and financial resources by activity
Actual
consumption of
Work Programme activity Executed budget 2024
the human
resources
1.1 Dossier preparation 26 6 929 896
1.2 Dossier submission and processing 34 8 480 661
1.3 Identification and prioritisation of substances and 41 10 115 816
groups of substances
1.4 Evaluation 86 16 784 194
1.5 Authorisation 29 6 132 956
1.6 Restrictions 30 6 318 755
1.7 Classification and labelling 33 6 517 743
1.8 Data management and dissemination 29 10 540 388
1.9 Promotion of alternatives to animal testing 4 1 316 944
2. Biocides 50 11 183 632
3. Environmental policy 25 4 841 570
4. Tasks under grant, cooperation and service-level 18 5 188 479
agreements
Governance and enablers 194 36 636 938
Overall TOTAL 599 130 987 971
101
Annual Report 2024
Annex VI – Contribution, grant and service-level agreements
Financial and HR
General information
impacts
Actual or
expected Total Short
Duration Counterpart 2023 2024
date of amount description
signature
Grant agreements
Amount
Number of
42 Commission 1.5 1.5
1. IPA 20.12.2022 675 103 CA
months DG NEAR
Number of
- -
SNEs
Amount
Number
1.5 1.5
of CA
Number
- -
of SNEs
Contribution agreements
Amount
5 years Number of
Commission 0 0
1. EUCLEF 10.12.2021 5 829 200 (2021- CA
DG GROW
2025) Number of
- -
SNEs
Amount
5 years Number of
Commission 3 3
2. EUON 09.12.2021 3 066 000 (2021- CA
DG GROW
2025) Number of
SNEs
Amount
3 years Commission Number of
0 0
3. SCBTH 15.11.2024 520 000 (2025- DG CA
2027) SANTE Number of
- -
SNEs
Amount
Number
3 3
of CA
Number
- -
of SNEs
Service-level agreements
Amount
1. IUCLID Annual fee of Number of
4 4
for 26.03.2021 784 712 plus N/A EFSA CA
EFSA project cost Number of
- -
SNEs
Amount
18-24 Number of
195 000 per Commission 4 4
2. OEL 23.02.2022 months CA
opinion DG EMPL
per case Number of
- -
SNEs
Amount
Number
8 8
Total service-level agreements of CA
Number
- -
of SNEs
Amount
TOTAL (contribution agreements and SLAs) Number
12.5 12.5
of CA
Number - -
of SNEs
102
Annual Report 2024
Annex VII - Environment management
Context of the Agency and its environmental management strategy
ECHA implements the EU’s chemicals legislation to protect health and the environment. Our work
also contributes to a well-functioning internal market, innovation and the competitiveness of
Europe’s chemicals industry.
Through ECHA’s work, better knowledge and regulation of harmful chemicals helps to protect
workers, consumers and the environment, makes recycling easier, and encourages industry to
develop safer alternatives.
ECHA has an environmental policy which commits ECHA to continually improve its environmental
performance. ECHA supports the political priorities of the EU, as enshrined in the European Green
Deal and the EUAN Strategy 2021-2027. To this end, ECHA has pledged to climate-neutral by
2030.
Finally, ECHA’s environmental objectives are fully aligned with the “Charter on greenhouse gases
(GHG) reduction and responsible environmental management”, adopted by the Head of EU
Agencies in February 2024, which set additional ambitious objectives to achieve Carbon
Neutrality by 2030.
Overview of the Agency's environmental management system
ECHA established an Environmental Management System (EMS) in 2015 - part of the Agency’s
integrated management system - which aims to deliver on ECHA’s strategy, vision, goals and
objectives. ECHA’s environmental objectives, targets and actions reflect our commitment to
incorporating sustainability measures within all areas of our activities. This is implemented
through our multi-annual environmental work programme (2023-2025) and the internal follow-
up of actions and reporting of progress.
In 2024, ECHA was recertified under ISO 14001:2015 standard (Environmental Management
System) and ECHA’s EMAS registration was renewed and extended until 2027.
103
Annual Report 2024
Environmental aspects, indicators and targets
104
Annual Report 2024
Actions taken to improve and communicate environmental performance
2024 was the second year of ECHA’s updated multi-annual Environmental Work Programme
(2023-2025) which maintained the previous objectives and introduced new actions and targets.
Goal Multi-annual work Actions implemented in
programme 2024
F1 Inform and involve all Green communications Promoted over 30 staff
staff in greening ECHA. plan, training and info information campaigns.
sessions.
Continue ECHA’s active Participated at 9 GIME and
participation in the EUAN GN meetings. Published
Greening Network of the the EUAN “Charter on
EU Agencies. greenhouse gases (GHG)
reduction and responsible
environmental management
on ECHA’s website.
F1 Inform and involve all Continue to develop Began developing a pilot
staff in greening ECHA. ECHA’s sustainability project on carbon capture to
reporting in all areas (for begin CO2 offsetting under the
example, energy and EU carbon removals and
climate). carbon farming certification
framework.
105
Annual Report 2024
F1 Inform and involve all Continue to develop Communicated the outcomes
staff in greening ECHA. ECHA’s sustainability and improvement areas of the
reporting in all areas (for 2024 ISO, EMAS, Internal
example, energy and Audit (under the IAC) and 2
climate). specific internal audits (under
the EMAS Regulation) of its
Environmental Management
System.
F3 Strengthen green public Develop and apply a GPP Further strengthened
procurement (GPP). checklist for environmental and
procurement. sustainability standards into
ECHA procurement (including
the canteen services) and
introduced Environmental
Certification requirements for
ICT services.
F4 Improve sustainability of Introduce relevant Introduced relevant guidelines
events. guidelines for for sustainable meeting
sustainable meeting organisation.
organisation.
F6 Extend scope of ECHA’s Establish baseline and Reviewed the scope of ECHA’s
carbon footprint. reduction targets for CO2 footprint and included
CO2 emissions from CO2 emissions from
teleworking, waste and teleworking and hotels nights
hotel nights. related staff travel in order to
ensure a comprehensive
overview and to avoid
reporting gaps and
reputational damage which will
be included in future
environmental reports.
EUROPEAN CHEMICALS AGENCY
P.O. BOX 400, FI-00121 HELSINKI, FINLAND
ECHA.EUROPA.EU
Saatja: "Webdesktop" <
[email protected]>
Saaja:
[email protected],
[email protected]
Teema: Webdesktop: Euroopa Kemikaaliameti aastaaruanne 2024
Kuupäev: 2025-04-29 08:35
Tere
Edastame
Reg. number: 10.2-11/378
Reg. kuupäev: 29.04.2025
Sisu: Euroopa Kemikaaliameti aastaaruanne 2024 / Annual Report 2024 of
the European Chemicals Agency
Parimat
Raili Lillemets
Sekretär
Eesti alaline esindus Euroopa Liidu juures
1 (1)
D(2025)0362
Helsinki, 28 April 2025 SMG/gsr
To the Permanent Representations of the EU Member States
Per email only
Subject: Annual Report 2024 of the European Chemicals Agency
Your Excellency,
Please find attached herewith the Annual Report 2024 of the European Chemicals Agency
(ECHA).
This Annual Report covers the period from 1 January 2024 to 31 December 2024. The report is
prepared pursuant to Article 83(3) of the REACH Regulation and Article 48 of ECHA’s Financial
Regulation. It consolidates the requirements of the REACH General Report and the Consolidated
Annual Activity Report (CAAR) under ECHA’s Financial Regulation.
The Annual Report 2024 will be available on our website (https://echa.europa.eu/plans-and-
reports) and contains the Management Board’s (MB) assessment of said report.
Should you or your services have any questions related to this Annual Report, please do not
hesitate to contact me.
Yours sincerely,
Dr Sharon McGuinness
Executive Director
Enclosure: Annual Report 2024 of the European Chemicals Agency
Cc.: Sofia Zisi, Chair of the ECHA Management Board
P.O. Box 400, FI-00121 Helsinki, Finland | Tel. +358 9 686180 | echa.europa.eu
Saatja: Webdesktop <
[email protected]>
Saadetud: 29.04.2025 11:35
Adressaat: <
[email protected]>; <
[email protected]>
Koopia: <"
[email protected]">
Teema: Webdesktop: Euroopa Kemikaaliameti aastaaruanne 2024
TereEdastameReg. number: 10.2-11/378Reg. kuupäev: 29.04.2025Sisu: Euroopa
Kemikaaliameti aastaaruanne 2024 / Annual Report 2024 of the European
Chemicals AgencyParimatRaili LillemetsSekretärEesti alaline esindus
Euroopa Liidu juures